"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B1,US 9093833 B1,099-817-705-773-563,2015-07-28,2015,US 32925008 A,2008-12-05,US 32925008 A,2008-12-05,Power factor correction apparatus for appliances having inductive loads,A power factor correction apparatus is retrofittable to an appliance having an inductive load. The apparatus includes a housing having an electrical socket on one side and an electrical plug on the other side. Inside the housing are a power factor correction circuit and a trigger circuit. The socket and plug are electrically coupled to each other by the trigger circuit which automatically couples the power factor correction circuit between the socket and the plug when current flowing to the appliance is sensed.,ELLENBOGEN RICHARD;;FORSYTHE DAVID;;POWER FACTOR CORRECTION LLC,ELLENBOGEN RICHARD;;FORSYTHE DAVID,POWER FACTOR CORRECTION LLC (2009-03-13),https://lens.org/099-817-705-773-563,Granted Patent,yes,27,3,1,1,0,G05F1/70;;H02H3/00;;H02H3/08;;Y02B40/00;;G05F1/70;;Y02B70/10,H02B1/04;;H01G4/228;;H02H3/00;;H02H3/08;;H05K7/00,,3,0,,,"William Rynone, Is Power Factor Correction Justified in the Home, Power Electronics Technology, May 2007, pp. 36-41.;;Whitby Hydro Energy Services Corp., Power Factor Correction at the Residential Level-Pilot Project, Sep. 12, 2005.;;Richard Ellenbogen, Distributed Generation, Customer Premise Loads & the Utility Network A Case Study, Feb. 1, 2008.",ACTIVE
2,US,B2,US 7164747 B2,194-006-272-810-078,2007-01-16,2007,US 67797603 A,2003-10-02,US 67797603 A;;US 41539102 P,2002-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES INC (2004-11-08),https://lens.org/194-006-272-810-078,Granted Patent,yes,46,67,21,23,0,G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226,G01N23/00;;A61B6/00;;G01N23/04;;G01V5/00;;G21K1/12;;H05G1/60,378/19;;378/5;;378/57,50,2,153-198-691-549-611;;150-208-079-162-362,10.1109/proc.1979.11542;;10.1088/0031-9155/43/4/013;;9572509,"International Search Report for PCT/US2004/001929, mailed Jul. 14, 2004.;;Affidavit of James Buckley in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Richard Bijjani in Opposition to Plaintiff's Patent Motions, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"", Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Elan Scheinman in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Patent Motions, Redacted Versions, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Emergency Motion, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;International Search Report for PCT/US03/31718; mailed Jun. 11, 2004.;;Aldo et al., ""Enhanced Integration, Data Fusion and Communication Protocols for Integrated Checked Baggage Explosives Detection Screening"", Nov. 2001,v pp. 1-5, REVL 4909-4913.;;Analogic product literature, ""the Exact: An Advanced Explosive Detection System"".;;de Moulpied et al., ""Security Management"", Mar. 1992, pp. 1-4, REVL 4855-4858.;;Eilbert et al., ""Aspects of Image Recognition in Vivid Technology's Dual-Energy X-Ray System for Explosive Detection"", Proceedings of the International Society for Optical Engineering, vol. 1824, Nov. 1992.;;Federal Register, ""Part IX, Department of Transportation"", Federal Aviation Administration, Explosives Detection Systems; Notices, Monday, Apr. 13, 1998.;;Fox, ""X-Ray Screening Uncovered"", Airport Safety Security Service, vol. 5, Oct. 2004.;;Heimann, ""Check-In Counter X-Ray System CS 5070"", REVL 4936-4941.;;Horn, ""Fan-Beam Reconstruction Methods"", A.I. Memo No. 448, Nov. 1977, REVL 05425-05468.;;Horn, ""Fan-Beam Reconstruction Methods"", Proceedings of the IEEE, 67(12):1616-1623 (1979), REVL 4759-4767.;;InVision Technologies, ""Technical Specifications"" for CTX9000 DSI.;;InVision Technologies, ""A Clear Vision, A Vital Mission"", REVL 4933-4935.;;InVision Technologies, ""A Clear Vision, A Vital Mission"", REVL 4778-4780.;;InVision Technologies, Product Announcement, Multiplexing for the CTX 9000 DSi, REVL 4772-4777.;;InVision Technologies, ""Image Archiving"", REVL 4897-4898.;;Kedem et al., ""Computed Tomography for Thick Steel Pipes and Castings"", Electric Power Research Institute, Dec. 1986, REVL 05565-05682.;;Kaiser Systems Inc. (KSI), OmniBlock X-Ray Source, REVL 4768-4769.;;L-3 Communications, literature for eXaminer 3DX6000, http://www.dsray.com/Linescan.asp?ProductCode=eXaminer6, Aug. 2, 2004, pp. 1-3.;;L-3 Communications, Security and Detection Systems, VividCT Series, www.bombdetection.com; Rev. Oct. 2002.;;Makky, ""Proceedings of the Second, Explosives Detection Technology Symposium and Aviation Security Technology Conference"", Nov. 1996, REVL 4781-4788.;;MUX Training, Apr. 2003, with CTX9000 DSI Product Announcement, REVL 4926-4932.;;Patrick et al., ""The Architecture of Secure Flow"", REVL 05288-05295.;;Peters, ""CT Image Reconstruction"", slides REVL 05697-05745, pp. 1-49.;;Rapiscan X-Ray Systems Maintenance Manual, Rev. Aug. 1995.;;Rayner et al., ""Threat Vector Solutions"", REVL 05283-05287.;;Silver, ""High-Helical-Pitch, Cone-Beam Computed Tomography"", Phys. Med. Biol., 43:847-855 (1998), REVL 05688-05696.;;Slide entitled L-Shaped Array (Conventional X-Ray Technology), 1 page.;;U.S. Army Medical Research Acquisition Activity, Contract DAMD17-87-C-7108, dated Jun. 1, 1987, REVL 05479-05487.;;Plaintiff's Amended Verified Complaint dated May 18, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Defendant's Answer dated May 24, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;The Reveal Parties' Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"", dated Nov. 2, 2004, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;The Court's ""Memorandum and Orders on Various Motions and Related Matters"" dated Dec. 2, 2004, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Decision On Petition In re Ellenbogen et al.;;Plaintiff's Second Set of Interrogatories to Defendants, dated Apr. 13, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Deposition of David A. Schafer dated Thursday, May 12, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel), including Exhibits: 1, 6, 7, 10-19.;;Defendents' Objections and Answers to Plaintiff's Second Set of Interrogatories, dated May 31, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Documents bearing production numbers REVL 05746 to REVL 05761 produced by the defendant in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Norbert J. Pelc dated Jul. 25, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel).;;Second Affidavit of Norbert J. Pelc dated Aug. 25, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel).;;Affidavit of Kristian Peschmann dated Jul. 15, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel); Exhibits A,B,C, and D.;;Affidavit of Frederick L. Roder date Jul. 24, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel). (Exhibits A and B).;;Roder, F.L., Proceedings: New Concepts Symposium and Workshop on Detection and Identification of Explosives, ""Explosives Detection by Dual-Energy Computerized Tomography"", Oct. 30, 31 and Nov. 1, 1978, pp. 317-325.",EXPIRED
3,US,B2,US 7046761 B2,108-076-172-110-044,2006-05-16,2006,US 76369504 A,2004-01-23,US 76369504 A;;US 44224603 P,2003-01-23,System and method for CT scanning of baggage,"The threat determination process for CT scan of baggage eliminates the need for complete reconstruction the bag. The CT scan data is analyzed during scanning to locate potential threats. The analysis is based upon a lineogram representing objects in the bag. The mass, size, location and atomic number of objects are determined based upon the lineogram data. Any potential threats are further subjected to data modification and reconstruction to enhance the view of the potential threat. Dual energy scanning may also be used to determine density for resolution of potential threats.",REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES (2005-10-18),https://lens.org/108-076-172-110-044,Granted Patent,yes,22,52,9,9,0,G01V5/226;;G01V5/226,G01N23/10;;G01N23/04;;G01V5/00,378/57,3,0,,,"International Search Report for PCT/US2004/001929, mailed Jul. 14, 2004.;;International Search Report for PCT/US2004/010240, mailed Dec. 27, 2004.;;International Search Report for PCT/US03/31718, mailed Nov. 6, 2004.",EXPIRED
4,US,A1,US 2006/0274879 A1,147-427-517-254-841,2006-12-07,2006,US 50345206 A,2006-08-11,US 50345206 A;;US 18449105 A;;US 97221104 A;;US 67797603 A,2003-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,L 3 COMM SECURITY & DETECTION,ELLENBOGEN MICHAEL;;BIIJANI RICHARD R,REVEAL IMAGING TECHNOLOGIES INC (2006-09-26),https://lens.org/147-427-517-254-841,Patent Application,yes,1,5,2,5,0,G01V5/224;;G01V5/226;;G01V5/226;;G01V5/224,H05G1/60;;A61B6/00;;G01N23/00;;G21K1/12,378/19,0,0,,,,EXPIRED
5,JP,A,JP 2009271080 A,097-145-492-834-913,2009-11-19,2009,JP 2009173729 A,2009-07-24,US 44224603 P,2003-01-23,SYSTEM AND METHOD FOR CT SCANNING OF HAND BAGGAGE,"<P>PROBLEM TO BE SOLVED: To provide a CT scanning system and a CT scanning method for analyzing unreconstructed scan data for specifying objects having potential threats. <P>SOLUTION: A hand baggage CT scanning method for determining objects having potential threats eliminates the need for complete reconstruction of bags. CT scan data is analyzed during scanning to specify the locations of potential threats. The analysis is based upon a chart representing objects in the bags. The mass, size, location and atomic number of objects are determined based upon the chart data. Any potential threats are further subjected to data modification and reconstruction to enhance the view of the threats. Dual energy scanning may also be used to determine density for resolution of potential threats. <P>COPYRIGHT: (C)2010,JPO&INPIT",REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/097-145-492-834-913,Patent Application,no,2,0,9,9,0,G01V5/226;;G01V5/226,G01N23/10;;G01N23/04;;G01V5/00,,0,0,,,,PENDING
6,US,B1,US 7039154 B1,175-511-133-966-644,2006-05-02,2006,US 19692705 A,2005-08-04,US 19692705 A;;US 67797603 A,2003-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES INC (2005-08-03),https://lens.org/175-511-133-966-644,Granted Patent,yes,4,47,3,5,0,A61B6/4266;;A61B6/482;;G01V5/224;;G01V5/226;;A61B6/482;;A61B6/4266;;G01V5/224;;G01V5/226,A61B6/00,378/19;;378/5;;378/57,0,0,,,,EXPIRED
7,US,A1,US 2005/0008118 A1,094-209-684-175-626,2005-01-13,2005,US 76369504 A,2004-01-23,US 76369504 A;;US 44224603 P,2003-01-23,System and method for CT scanning of baggage,"The threat determination process for CT scan of baggage eliminates the need for complete reconstruction the bag. The CT scan data is analyzed during scanning to locate potential threats. The analysis is based upon a lineogram representing objects in the bag. The mass, size, location and atomic number of objects are determined based upon the lineogram data. Any potential threats are further subjected to data modification and reconstruction to enhance the view of the potential threat. Dual energy scanning may also be used to determine density for resolution of potential threats.",ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES (2005-10-18),https://lens.org/094-209-684-175-626,Patent Application,yes,15,6,9,9,0,G01V5/226;;G01V5/226,G01N23/04;;G01V5/00,378/57,0,0,,,,EXPIRED
8,US,B2,US 7440537 B2,087-082-112-971-441,2008-10-21,2008,US 58284706 A,2006-10-17,US 58284706 A;;US 67797603 A,2003-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,,https://lens.org/087-082-112-971-441,Granted Patent,yes,48,6,3,5,0,A61B6/4266;;A61B6/482;;G01V5/224;;G01V5/226;;A61B6/482;;A61B6/4266;;G01V5/224;;G01V5/226,G01N23/00,378/19;;378/5;;378/57,48,2,153-198-691-549-611;;150-208-079-162-362,10.1109/proc.1979.11542;;10.1088/0031-9155/43/4/013;;9572509,"Affidavit of James Buckley in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Richard Bijjani in Opposition to Plaintiff's Patent Motions, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"", Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Elan Scheinman in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Emergency Motion, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Aldo et al., ""Enhanced Integration, Data Fusion and Communication Protocols for Integrated Checked Baggage Explosives Detection Screening"", Nov. 2001,v pp. 1-5, REVL 4909-4913.;;Analogic product literature, ""the Exact: An Advanced Explosive Detection System"".;;de Moulpied et al., ""Security Management"", Mar. 1992, pp. 1-4, REVL 4855-4858.;;Eilbert et al., ""Aspects of Image Recognition in Vivid Technology's Dual-Energy X-Ray System for Explosive Detection"", Proceedings of the International Society for Optical Engineering, vol. 1824, Nov. 1992.;;Federal Register, ""Part IX, Department of Transportation"", Federal Aviation Administration, Explosives Detection Systems; Notices, Monday, Apr. 13, 1998.;;Fox, ""X-Ray Screening Uncovered"", Airport Safety Security Service, vol. 5, Oct. 2004.;;Heimann, ""Check-In Counter X-Ray System CS 5070"", REVL 4936-4941.;;Horn, ""Fan-Beam Reconstruction Methods"", A.I. Memo No. 448, Nov. 1977, REVL 05425-05468.;;Horn, ""Fan-Beam Reconstruction Methods"", Proceedings of the IEEE, 67(12):1616-1623 (1979), REVL 4759-4767.;;InVision Technologies, ""Technical Specifications"" for CTX9000 DSI.;;InVision Technologies, ""A Clear Vision, A Vital Mission"", REVL 4933-4935.;;InVision Technologies, ""A Clear Vision, A Vital Mission"", REVL 4778-4780.;;InVision Technologies, Product Announcement, Multiplexing for the CTX 9000 DSi, REVL 4772-4777.;;InVision Technologies, ""Image Archiving"", REVL 4897-4898.;;Kedem et al., ""Computed Tomography for Thick Steel Pipes and Castings"", Electric Power Research Institute, Dec. 1986, REVL 05565-05682.;;Kaiser Systems Inc. (KSI), OmniBlock X-Ray Source, REVL 4768-4769.;;L-3 Communications, literature for eXaminer 3DX6000, http://www.dsray.com/Linescan.asp?ProductCode=eXaminer6, Aug. 2, 2004, pp. 1-3.;;L-3 Communications, Security and Detection Systems, VividCT Series, www.bombdetection.com; Rev. Oct. 2002.;;Makky, ""Proceedings of the Second, Explosives Detection Technology Symposium and Aviation Security Technology Conference"", Nov. 1996, REVL 4781-4788.;;MUX Training, Apr. '03, with CTX9000 DSI Product Announcement, REVL 4926-4932.;;Patrick et al., ""The Architecture of Secure Flow"", REVL 05288-05295.;;Peters, ""CT Image Reconstruction"", slides REVL 05697-05745, pp. 1-49.;;Rapiscan X-Ray Systems Maintenance Manual, Rev. Aug. 1995.;;Rayner et al., ""Threat Vector Solutions"", REVL 05283-05287.;;Silver, ""High-Helical-Pitch, Cone-Beam Computed Tomography"", Phys. Med. Biol., 43:847-855 (1998), REVL 05688-05696.;;Slide entitled L-Shaped Array (Conventional X-Ray Technology), 1 page.;;U.S. Army Medical Research Acquisition Activity, Contract DAMD17-87-C-7108, dated Jun. 1, 1987, REVL 05479-05487.;;Plaintiff's Amended Verified Complaint dated May 18, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Defendant's Answer dated May 24, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;The Reveal Parties' Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"", dated Nov. 2, 2004, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;The Court's ""Memorandum and Orders on Various Motions and Related Matters"" dated Dec. 2, 2004, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Decision On Petition In re Ellenbogen et al.;;Plaintiff's Second Set of Interrogatories to Defendants, dated Apr. 13, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Deposition of David A. Schafer dated Thursday, May 12, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel), including Exhibits: 1, 6, 7, 10-19.;;Defendants' Objections and Answers to Plaintiff's Second Set of Interrogatories, dated May 31, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Documents bearing production Nos. REVL 05746 to REVL 05761 produced by the defendant in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Norbert J. Pelc dated Jul. 25, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel).;;Second Affidavit of Norbert J. Pelc dated Aug. 25, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel).;;Affidavit of Kristian Peschmann dated Jul. 15, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel); Exhibits A,B,C, and D.;;Affidavit of Frederick L. Roder date Jul. 24, 2005 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department of the Trial Court, Business Litigation Session C.A. No. 03-5810-BLS (Judge van Gestel). (Exhibits A and B).;;Roder, F.L., Proceedings: New Concepts Symposium and Workshop on Detection and Identification of Explosives, ""Explosives Detection by Dual-Energy Computerized Tomography"", Oct. 30, 31 and Nov. 1, 1978, pp. 317-325.",EXPIRED
9,US,B2,US 7016459 B2,149-763-665-703-800,2006-03-21,2006,US 97221104 A,2004-10-21,US 97221104 A;;US 67797603 A;;US 41539102 P,2002-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,L 3 COMM SECURITY & DETECTION,ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,PERKINELMER DETECTION SYSTEMS INC. (A MASSACHUSETTS CORPORATION) (2000-06-14);;L-3 COMMUNICATIONS SECURITY AND DETECTION SYSTEMS CORPORATION (2002-07-17);;REVEAL IMAGING TECHNOLOGIES INC (2004-11-08);;L-3 COMMUNICATIONS SECURITY AND DETECTION SYSTEMS INC (2004-06-28),https://lens.org/149-763-665-703-800,Granted Patent,yes,41,50,21,23,0,G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226,G01N23/00;;A61B6/00;;G01N23/04;;G01V5/00;;G21K1/12;;H05G1/60,378/19;;378/57,44,1,150-208-079-162-362,10.1088/0031-9155/43/4/013;;9572509,"U.S. Appl. No. 10/971,453, filed Oct. 21, 2001, Ellenbogen.;;Affidavit of James Buckley in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Richard Biijani in Opposition to Plaintiff's Patent motions, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"", Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Elan Scheinman in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Emergency Motion, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Plaintiff's Amended Verified Complaint dated May 18, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Defendant's Answer dated May 24, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc. Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;The Court's ""Memorandum and Orders on Various Motions and Related Matters"" dated Dec. 2, 2004, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Decision On Petition in In re Ellenbogen, et al.;;International Search Report for PCT/US2003/31718, mailed Jun. 11, 2004.;;International Search Report for PCT/US2004/001929, mailed Jul. 14, 2004.;;Eilbert and Krug, ""Aspects of Image Recognition in Vivid Technology's Dual-energy X-ray System for Explosive Detection,"" Proceedings of the International Society for Optical Engineering, vol. 1824, Nov. 1992.;;Documents bearing production Nos. REVL 05746 to REVL 05761 produced by the defendant in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Nick Fox, ""X-ray Screening Uncovered"" Airport Safety Security Service, vol. 5, Oct. 2004.;;InVision Technologies, ""Technical Specifications"" for CTX9000 DSI.;;L-3 Communications, literature for eXaminer 3DX6000, http://www.dsxray.com/Linescan.asp?ProductCode=eXaminer6, Aug. 2, 2004, pp. 1-3.;;Analogic product literature, ""The Exact: An Advanced Explosive Detection System,"".;;Federal Register, ""Part IX, Department of Transportation,"" Federal Aviation Admin., Explosives Detection Systems; Notices, Monday Apr. 13, 1998.;;L-3 Communications Security and Detection Systems, Inc., VividCT Series, www/bombdetection.com; Rev. Oct. 2002.;;Rapiscan X-ray System Maintenance Manual 1995.;;Terry Peters, ""CT Image Reconstruction,"" SLIDES REVL 05697-05745, pp. 1-49.;;Michael D. Silver, ""High-helical-pitch, cone-beam computed tomography,"" Phys. Med. Biol., 43 (1998) 847-855, REVL 05688-05696.;;Dan Kedem, et al, ""Computed Tomography for Thick Steel Pipes and Castings,"" Electric Power Research Inst., Dec. 1986, REVL 05565-05682.;;U.S. Army Medical Research Acquisition Activity, Contract DAMD17-87-C-7108, Dated Jun. 1, 1987; REVL 05479-05487.;;Berthold K.P. Horn, ""Fan-Beam Reconstruction Methods,"" A.I. Memo No. 448, Nov. 1977 REVL 05425-05469.;;Patrick Michael, et al, ""The Architecture of Secure Flow,"" REVL 05288-05295.;;Tim Rayner et al., ""Threat Vector Solutions,"" REVL 05283-05287.;;Heimann, Check-In Counter X-Ray System CS 5070, REVL 4936-4941.;;MUX Training, Apr. '03, with CTX9000 DSI Product Announcement, REVL 4926-4932.;;InVision Technologies, ""A Clear Vision, A Vital Mission,"" REVL 4933-4935.;;Jim Aldo et al., ""Enhanced Integration, Data Fusion and Communication Protocols for Integrated Checked Baggage Explosives Detection Screening,"" Nov. 1996, pp. 385-390,REVL 4909-4913.;;Dr. Wagih Hassan Makky, ""Proceedings of the Second, Explosives Detection Technology Symposium & Aviation Security Technology Conference,"" REVL 4781-4788.;;David S. de Moulpied et al., Security Management, Mar. 1992, REVL 4855-4898.;;InVision Technologies, ""A Clear Vision, A Vital Mission,"" REVL 4778-4780.;;InVision Technologies, Product Announcement, Multiplexing for the CTX 9000 DSi, REVL 4772-4777.;;""Proceedings, IEEE Dec. 1979, Collecting Data with Fan Beams,"" REVL 4759-4767.;;KSI Kaiser System Inc., OmniBlock X-Ray Source, REVL 4768-4769-.;;Invision Technologies, Image Archiving, REVL 4897-4898.;;Slide entitled L-Shaped Array (Conventional X-Ray Technology).;;The Reveal Parties' Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"" in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial COurt, Civil No. 03-05810-BLS (Justice van Gestel).;;Deposition of David A. Schafer dated Thursday, May 12, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel). including exhibits 1, 6, 7, 10-19.",EXPIRED
10,US,B2,US 7333589 B2,164-223-222-700-287,2008-02-19,2008,US 41769206 A,2006-05-03,US 41769206 A;;US 76369504 A;;US 44224603 P,2003-01-23,System and method for CT scanning of baggage,"The threat determination process for CT scan of baggage eliminates the need for complete reconstruction the bag. The CT scan data is analyzed during scanning to locate potential threats. The analysis is based upon a lineogram representing objects in the bag. The mass, size, location and atomic number of objects are determined based upon the lineogram data. Any potential threats are further subjected to data modification and reconstruction to enhance the view of the potential threat. Dual energy scanning may also be used to determine density for resolution of potential threats.",REVEAL IMAGING TECHNOLOGIES,ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/164-223-222-700-287,Granted Patent,yes,24,31,9,9,0,G01V5/226;;G01V5/226,G01N23/083;;G01N23/04;;G01V5/00,378/57,0,0,,,,EXPIRED
11,WO,A1,WO 2004/065990 A1,110-167-370-095-063,2004-08-05,2004,US 2004/0001929 W,2004-01-23,US 44224603 P,2003-01-23,SYSTEM AND METHOD FOR CT SCANNING OF BAGGAGE,"The threat determination process for CT scan of baggage eliminates the need for complete reconstruction the bag. The CT scan data is analyzed during scanning to locate potential threats. The analysis is based upon a lineogram representing objects in the bag. The mass, size, location and atomic number of objects are determined based upon the lineogram data. Any potential threats are further subjected to data modification and reconstruction to enhance the view of the potential threat. Dual energy scanning may also be used to determine density for resolution of potential threats.",REVEAL IMAGING TECHNOLOGIES IN;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/110-167-370-095-063,Patent Application,yes,2,3,9,9,0,G01V5/226;;G01V5/226,G01N23/04;;G01V5/00,,0,0,,,,PENDING
12,EP,A1,EP 1585995 A1,110-791-956-254-729,2005-10-19,2005,EP 04704958 A,2004-01-23,US 2004/0001929 W;;US 44224603 P,2003-01-23,SYSTEM AND METHOD FOR CT SCANNING OF BAGGAGE,,REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/110-791-956-254-729,Patent Application,yes,0,2,9,9,0,G01V5/226;;G01V5/226,G01N23/04;;G01V5/00,,0,0,,,,DISCONTINUED
13,US,A1,US 2004/0120454 A1,079-868-644-588-974,2004-06-24,2004,US 67797603 A,2003-10-02,US 67797603 A;;US 41539102 P,2002-10-02,Folded array CT baggage scanner,"
   A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners. 
",ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,ELLENBOGEN MICHAEL;;BIIJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES INC (2004-11-08),https://lens.org/079-868-644-588-974,Patent Application,yes,34,90,21,23,0,G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226,A61B6/00;;G01N23/00;;G01N23/04;;G01V5/00;;G21K1/12;;H05G1/60,378/19,0,0,,,,EXPIRED
14,US,A1,US 2007/0147581 A1,023-268-676-414-521,2007-06-28,2007,US 58284706 A,2006-10-17,US 58284706 A;;US 67797603 A,2003-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL;;BIIJANI RICHARD R,,https://lens.org/023-268-676-414-521,Patent Application,yes,40,7,3,5,0,A61B6/4266;;A61B6/482;;G01V5/224;;G01V5/226;;A61B6/482;;A61B6/4266;;G01V5/224;;G01V5/226,A61B6/00;;H05G1/60;;G01N23/00;;G21K1/12,378/19,0,0,,,,EXPIRED
15,US,A1,US 2005/0249330 A1,128-975-415-779-047,2005-11-10,2005,US 18449105 A,2005-07-19,US 18449105 A;;US 97221104 A;;US 67797603 A;;US 41539102 P,2002-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,L 3 COMM SECURITY & DETECTION,ELLENBOGEN MICHAEL;;BIIJANI RICHARD R,REVEAL IMAGING TECHNOLOGIES INC (2006-09-26);;L-3 COMMUNICATIONS SECURITY AND DETECTION SYSTEMS INC (2004-06-28),https://lens.org/128-975-415-779-047,Patent Application,yes,38,1,21,23,0,G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226,A61B6/00;;G01N23/00;;G01N23/04;;G01V5/00;;G21K1/12;;H05G1/60,378/19,0,0,,,,EXPIRED
16,US,A1,US 2006/0198495 A1,062-715-120-106-060,2006-09-07,2006,US 41769206 A,2006-05-03,US 41769206 A;;US 76369504 A;;US 44224603 P,2003-01-23,System and method for CT scanning of baggage,"The threat determination process for CT scan of baggage eliminates the need for complete reconstruction the bag. The CT scan data is analyzed during scanning to locate potential threats. The analysis is based upon a lineogram representing objects in the bag. The mass, size, location and atomic number of objects are determined based upon the lineogram data. Any potential threats are further subjected to data modification and reconstruction to enhance the view of the potential threat. Dual energy scanning may also be used to determine density for resolution of potential threats.",REVEAL IMAGING TECHNOLOGIES,ELLENBOGEN MICHAEL;;BIJJANI RICHARD R,,https://lens.org/062-715-120-106-060,Patent Application,yes,17,0,9,9,0,G01V5/226;;G01V5/226,G01V5/00;;G01N23/04,378/57,0,0,,,,EXPIRED
17,US,B2,US 7352841 B2,046-727-537-642-49X,2008-04-01,2008,US 50345206 A,2006-08-11,US 50345206 A;;US 18449105 A;;US 97221104 A;;US 67797603 A,2003-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL P;;BIJJANI RICHARD R,REVEAL IMAGING TECHNOLOGIES INC (2006-09-26),https://lens.org/046-727-537-642-49X,Granted Patent,yes,1,6,2,5,0,G01V5/224;;G01V5/226;;G01V5/226;;G01V5/224,G01N23/00,378/19;;378/57,0,0,,,,EXPIRED
18,US,A1,US 2005/0169423 A1,133-298-988-590-466,2005-08-04,2005,US 97221104 A,2004-10-21,US 97221104 A;;US 67797603 A;;US 41539102 P,2002-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,L 3 COMM SECURITY & DETECTION,ELLENBOGEN MICHAEL P;;BIIJANI RICHARD R,PERKINELMER DETECTION SYSTEMS INC. (A MASSACHUSETTS CORPORATION) (2000-06-14);;L-3 COMMUNICATIONS SECURITY AND DETECTION SYSTEMS CORPORATION (2002-07-17);;REVEAL IMAGING TECHNOLOGIES INC (2004-11-08);;L-3 COMMUNICATIONS SECURITY AND DETECTION SYSTEMS INC (2004-06-28),https://lens.org/133-298-988-590-466,Patent Application,yes,26,17,21,23,0,G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226,A61B6/00;;G01N23/00;;G01N23/04;;G01V5/00;;G21K1/12;;H05G1/60,378/57,0,0,,,,EXPIRED
19,US,B2,US 7123681 B2,071-934-072-503-85X,2006-10-17,2006,US 18449105 A,2005-07-19,US 18449105 A;;US 97221104 A;;US 67797603 A;;US 41539102 P,2002-10-02,Folded array CT baggage scanner,A reduced size CT scanner for baggage inspection has a wide angle x-ray source and multiple sets of detectors at different distances from the x-ray source. The detectors in each set are sized and positioned to maintain consistent pitch and flux levels among all detectors. Conventional reconstruction processes can be used to process the data from the CT scanner. The scanner may also be incorporated into a check-in desk in a network of scanners.,L 3 COMM SECURITY & DETECTION,ELLENBOGEN MICHAEL P;;BIJJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES INC (2006-09-26);;L-3 COMMUNICATIONS SECURITY AND DETECTION SYSTEMS INC (2004-06-28),https://lens.org/071-934-072-503-85X,Granted Patent,yes,47,29,21,23,0,G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226;;G01N23/046;;G01N2223/419;;G01V5/224;;G01V5/226,G01N23/00;;A61B6/00;;G01N23/04;;G01V5/00;;G21K1/12;;H05G1/60,378/19;;378/57,50,1,150-208-079-162-362,10.1088/0031-9155/43/4/013;;9572509,"U.S. Appl. No. 10/971,453, filed Oct. 21, 2001, Ellenbogen.;;Defandants' Objections and Answers to Plaintiff's Second Set of Interrogatories, dated May 31, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Michael Ellenbogen, Richard Bijjani, James Buckley, Bruce Lee, John Sanders and Elan Scheinman, Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810 BLSI (Justice van Gestel).;;Plaintiff's Second Set of Interrogatories to Defendants, dated Apr. 13, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., et al., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810 BLSI (Justice van Gestel).;;Nick Fox, ""X-ray Screening Uncovered"" Airport Safety Security Service, vol. 5, Oct. 2004.;;In Vision Technologies, ""Technical Specifications"" for CTX9000 DSI.;;L-3 Communications, literature for eXaminer 3DX6000, http://www.dsxray.com/Linescan.asp?ProductCode=eXaminer6, Aug. 2, 2004, pp. 1-3.;;Analogic product literature, ""The Exact: An Advanced Explosive Detection System,"".;;Federal Register, ""Part IX, Department of Transportation,"" Federal Aviation Admin., Explosives Detection Systems; Notices, Monday Apr. 13, 1998.;;L-3 Communications Security and Detection Systems, Inc., VividCT Series, www/bombdetection.com; Rev. Oct. 2002.;;Rapiscan X-ray System Maintenance Manual 1995.;;Terry Peters, ""CT Image Reconstruction,"" SLIDES REVL 05697-05745, pp. 1-49.;;Michael D. Silver, ""High-helical-pitch, cone-beam computed tomography,"" Phys. Med. Biol., 43 (1998) 847-855, REVL 05688-05696.;;Dan Kedem, et al, ""Computed Tomography for Thick Steel Pipes and Castings,"" Electric Power Research Inst., Dec. 1986, REVL 05565-05682.;;U.S. Army Medical Research Acquisition Activity, Contract DAMD17-87-C-7108, Dated Jun. 1, 1987; REVL 05479-05487.;;Berthold K.P. Horn, ""Fan-Beam Reconstruction Methods,"" A.I. Memo No. 448, Nov. 1977 REVL 05425-05469.;;Patrick Michael, et al, ""The Architecture of Secure Flow,"" REVL 05288-05295.;;Tim Rayner et al., ""Threat Vector Solutions,"" REVL 05283-05287.;;Heimann, Check-In Counter X-Ray System CS 5070, REVL 4936-4941.;;MUX Training, Apr. '03, with CTX9000 DSI Product Announcement, REVL 4926-4932.;;InVision Technologies, ""A Clear Vision, A Vital Mission,"" REVL 4933-4935.;;Jim Aldo et al., ""Enhanced Integration, Data Fusion and Communication Protocols for Integrated Checked Baggage Explosives Detection Screening,"" Nov. 1996, pp. 385-390, REVL 4909-4913.;;Dr. Wagih Hassan Makky, ""Proceedings of the Second, Explosives Detection Technology Symposium & Aviation Security Technology Conference,"" REVL 4781-4788.;;David S. de Moulpied et al., Security Management, Mar. 1992, REVL 4855-4898.;;InVision Technologies, ""A Clear Vision, A Vital Mission,"" REVL 4778-4780.;;InVision Technologies, Product Announcement, Multiplexing for the CTX 9000 DSi, REVL 4772-4777.;;""Proceedings, IEEE Dec. 1979, Collecting Data with Fan Beams,"" REVL 4759-4769.;;KSI Kaiser System Inc., OmniBlock X-Ray Source, REVL 4768-4769.;;Invision Technologies, Image Archiving, REVL 4897-4898.;;Slide entitled L-Shaped Array (Conventional X-Ray Technology).;;The Reveal Parties' Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"" in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Deposition of David A. Schafer dated Thursday, May 12, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel). including exhibits 1,6,7,10-19.;;Documents bearing production numbers REVL 05746 to REVL 05761 produced by the defendant in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of James Buckley in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Richard Bijjani in Opposition to Plaintiff's Patent motions, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Emergency Motion Regarding ""Newly Found Evidence"", Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Elan Scheinman in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of A. W. Phinney in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Emergency Motion, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Affidavit of Michael Ellenbogen in Opposition to Plaintiff's Patent Motions, Redacted Version, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Plaintiff's Amended Verified Complaint dated May 18, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Defendant's Answer dated May 24, 2004 in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;The Court's ""Memorandum and Orders on Various Motions and Related Matters"" on Dec. 2, 2004, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Decision On Petition in In re Ellenbogen, et al.;;International Search Report for PCT/US2003/31718, mailed Jun. 11, 2004.;;International Search Report for PCT/US2004/001929, mailed Jul. 14, 2004.;;Eilbert and Krug, ""Aspects of Image Recognition in Vivid Technology's Dual-energy X-ray System for Explosive Detection,"" Proceedings of the International Society for Optical Engineering, vol. 1824, Nov. 1992.;;Decision on Petition, In Re: Ellenbogen et al., Apr. 22, 2005.;;The Reveal Parties' Supplemental Answers to Plaintiff's Second Set of Interrogatories, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc. , Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS (Justice van Gestel).;;Exhibits 6-8 from the Reveal Parties Memorandum in Support of Their Motion for Summary Judgment Concerning Plaintiff's Purported Trade Secrets #1 and #2, dated Aug. 2, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Department (BLS) of the Trial Court, Civil No. 03-05810-BLS1 (Justice van Gestel).;;Second Affidavit of Norbert J. Pelc dated Aug. 25, 2005, in a case entitled L-3 Communications Security and Detection Systems Corporation Delaware v. Reveal Imaging Technologies, Inc., Commonwealth of Massachusetts, Superior Court Dept. of the Trial Court, Civil Action No. 03-5810-BLS (Judge van Gestel).",EXPIRED
20,US,A1,US 2005/0195939 A1,003-690-155-319-551,2005-09-08,2005,US 5647605 A,2005-02-11,US 5647605 A;;US 54376804 P,2004-02-11,Contraband detection systems and methods,"In one embodiment, the present invention provides a CT scanner system for use in baggage screening at security checkpoints.",SCHEINMAN ELAN D.;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD R.,SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD R,REVEAL IMAGING TECHNOLOGIES INC (2005-04-08),https://lens.org/003-690-155-319-551,Patent Application,yes,14,18,7,7,0,G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226;;G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226,G01N23/04;;G01V5/00,378/57,0,0,,,,ACTIVE
21,EP,A2,EP 1719000 A2,080-806-547-087-117,2006-11-08,2006,EP 05758745 A,2005-02-11,US 2005/0004675 W;;US 54376804 P,2004-02-11,CONTRABAND DETECTION SYSTEMS AND METHODS,,REVEAL IMAGING TECHNOLOGIES IN,SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/080-806-547-087-117,Patent Application,yes,0,0,7,7,0,G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226;;G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226,G01V5/00;;G01N23/04,,0,0,,,,DISCONTINUED
22,WO,A2,WO 2005/095931 A2,090-280-967-877-253,2005-10-13,2005,US 2005/0004675 W,2005-02-11,US 54376804 P,2004-02-11,CONTRABAND DETECTION SYSTEMS AND METHODS,"In one embodiment, the present invention provides a CT scanner system for use in baggage screening at security checkpoints.",REVEAL IMAGING TECHNOLOGIES IN;;SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/090-280-967-877-253,Patent Application,yes,0,11,7,7,0,G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226;;G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226,G01N23/04;;G01V5/00,,0,0,,,,PENDING
23,US,B2,US 7440544 B2,184-018-956-813-638,2008-10-21,2008,US 5647605 A,2005-02-11,US 5647605 A;;US 54376804 P,2004-02-11,Contraband detection systems and methods,"A system and method for baggage screening at security checkpoints. A CT scanner system processes x-ray data to locate and eliminate non-contraband without a full CT reconstruction of the entire bag. The CT scanner system utilizes lineogram data to disqualify objects of insufficient size, density, or mass as potential threats. Objects can be inspected with CT reconstruction. The CT scanner is capable of obtaining CT data and projection images. Multiple CT scanning systems can be multiplexed together, and each CT scanning system is in communication with a review station. Baggage scanning may also be based on security intelligence inputs such as CAPPS to increase throughput.",REVEAL IMAGING TECHNOLOGIES IN,SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES INC (2005-04-08),https://lens.org/184-018-956-813-638,Granted Patent,yes,21,25,7,7,0,G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226;;G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226,G01N23/04;;G01V5/00,378/57;;378/4,0,0,,,,ACTIVE
24,WO,A3,WO 2005/095931 A3,055-749-033-076-096,2006-05-18,2006,US 2005/0004675 W,2005-02-11,US 54376804 P,2004-02-11,CONTRABAND DETECTION SYSTEMS AND METHODS,"In one embodiment, the present invention provides a CT scanner system for use in baggage screening at security checkpoints.",REVEAL IMAGING TECHNOLOGIES IN;;SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,,https://lens.org/055-749-033-076-096,Search Report,yes,6,0,7,7,0,G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226;;G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226,G01N23/04;;G01V5/00,,2,0,,,"SUBCOMMITTEE ON AVIATION (107TH CONGRESS, 2ND SESSION): ""Aviation Security with a Focus on Passenger Profiling"", INTERNET ARTICLE, 27 February 2002 (2002-02-27), XP002367125, Retrieved from the Internet <URL:http://www.house.gov/transportation/aviation/02-27-02/02-27-02memo.html>;;PATENT ABSTRACTS OF JAPAN vol. 1998, no. 10 31 August 1998 (1998-08-31)",PENDING
25,US,B2,US 7702068 B2,184-341-429-384-245,2010-04-20,2010,US 58813805 A,2005-02-11,US 58813805 A;;US 54376804 P;;US 2005/0004675 W,2004-02-11,Contraband detection systems and methods,"In one embodiment, the present invention provides a CT scanner system for use in baggage screening at security checkpoints.",REVEAL IMAGING TECHNOLOGIES IN,SCHEINMAN ELAN D;;ELLENBOGEN MICHAEL;;BIJJANI RICHARD ROBEHR,REVEAL IMAGING TECHNOLOGIES INC (2009-11-06),https://lens.org/184-341-429-384-245,Granted Patent,yes,16,11,7,7,0,G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226;;G01N23/046;;G01N2223/419;;Y10S378/901;;G01V5/226,G01N23/04;;G01V5/00,378/57;;378/4;;378/901,0,0,,,,ACTIVE
26,WO,A1,WO 2023/122181 A1,006-205-432-886-229,2023-06-29,2023,US 2022/0053668 W,2022-12-21,US 202163293597 P,2021-12-23,IRON OXIDE NANOPARTICLE-MEDIATED RADIATION DELIVERY FOR TARGETED CANCER TREATMENT,Method for nanoparticle-mediated deposition of radiation (NMDR) and targeted radiation therapies using a biodegradable and bioabsorbable iron oxide nanoparticle with a biocompatible coating that is effective to overcome various extra- and intra-cellular barriers and selectively accumulate in solid and metastatic tumors to improve the energy transfer of conventional radiotherapy,UNIV WASHINGTON,ZHANG MIQIN;;CHIARELLI PETER;;REVIA RICHARD;;STEPHEN ZACHARY;;KIEVIT FORREST;;WANG KUI;;ELLENBOGEN RICHARD,,https://lens.org/006-205-432-886-229,Patent Application,yes,5,0,1,1,0,B82Y5/00;;A61K33/26;;A61K41/0038;;A61P35/00;;H01F1/0054;;C01G49/06,B82Y30/00;;A61K33/26;;B82Y5/00;;B82Y40/00;;C01G49/02,,0,0,,,,PENDING
27,WO,A1,WO 2009/143169 A1,004-643-758-479-647,2009-11-26,2009,US 2009/0044540 W,2009-05-19,US 5444108 P,2008-05-19,X-RAY APPARATUS FOR INSPECTING LUGGAGE USING X-RAY SOURCES EMITTING A PLURALITY OF FAN-SHAPED BEAMS,"Embodiments of an Array CT scanning system for x-ray scanning objects (e.g., scanning airline baggage, packages, and cargo) can include a conveyor configured to transport baggage through a tunnel, a bottom mounted x-ray source configured to provide five fan beams through the tunnel, a side mounted x-ray source disposed at a height higher than the conveyor and configured to provide a fan beam through the tunnel, and a plurality of detectors disposed across the arcs of each of the fan beams. An image processing system can be configured to provide 3D type images of a scanned bag as a function of the information received from the detectors. The images can be derived through interpolation of the scan data. An operator can manipulate the image data and partially rotate the bag to discern objects located within. A side tray is provided to allow an operator to remove a suspect bag from an operational flow of bags. Image information can be stored for subsequent review. Multiple scanners can be networked together such that image and passenger information can be transferred to other workstations.",REVEAL IMAGING TECHNOLIGIES IN;;ELLENBOGEN MICHAEL P;;BIJJANI RICHARD;;LITCHFIELD MICHAEL;;CONWAY PETER;;AITKENHEAD WILLIAM;;LEE BRUCE,ELLENBOGEN MICHAEL P;;BIJJANI RICHARD;;LITCHFIELD MICHAEL;;CONWAY PETER;;AITKENHEAD WILLIAM;;LEE BRUCE,,https://lens.org/004-643-758-479-647,Patent Application,yes,4,25,5,5,0,G01V5/226;;G01V5/226,G01V5/00,,0,0,,,,PENDING
28,WO,A8,WO 2009/143169 A8,120-197-721-000-645,2011-02-17,2011,US 2009/0044540 W,2009-05-19,US 5444108 P,2008-05-19,X-RAY APPARATUS FOR INSPECTING LUGGAGE USING X-RAY SOURCES EMITTING A PLURALITY OF FAN-SHAPED BEAMS,"Embodiments of an Array CT scanning system for x-ray scanning objects (e.g., scanning airline baggage, packages, and cargo) can include a conveyor configured to transport baggage through a tunnel, a bottom mounted x-ray source configured to provide five fan beams through the tunnel, a side mounted x-ray source disposed at a height higher than the conveyor and configured to provide a fan beam through the tunnel, and a plurality of detectors disposed across the arcs of each of the fan beams. An image processing system can be configured to provide 3D type images of a scanned bag as a function of the information received from the detectors. The images can be derived through interpolation of the scan data. An operator can manipulate the image data and partially rotate the bag to discern objects located within. A side tray is provided to allow an operator to remove a suspect bag from an operational flow of bags. Image information can be stored for subsequent review. Multiple scanners can be networked together such that image and passenger information can be transferred to other workstations.",REVEAL IMAGING TECHNOLIGIES INC;;ELLENBOGEN MICHAEL P;;BIJJANI RICHARD;;LITCHFIELD MICHAEL;;CONWAY PETER;;AITKENHEAD WILLIAM;;LEE BRUCE,ELLENBOGEN MICHAEL P;;BIJJANI RICHARD;;LITCHFIELD MICHAEL;;CONWAY PETER;;AITKENHEAD WILLIAM;;LEE BRUCE,,https://lens.org/120-197-721-000-645,Amended Application,yes,0,0,5,5,0,G01V5/226;;G01V5/226,G01V5/00,,0,0,,,,PENDING
29,EP,A1,EP 2291687 A1,022-131-203-473-43X,2011-03-09,2011,EP 09751397 A,2009-05-19,US 2009/0044540 W;;US 5444108 P,2008-05-19,X-RAY APPARATUS FOR INSPECTING LUGGAGE USING X-RAY SOURCES EMITTING A PLURALITY OF FAN-SHAPED BEAMS,,REVEAL IMAGING TECHNOLIGIES INC,ELLENBOGEN MICHAEL P;;BIJJANI RICHARD;;LITCHFIELD MICHAEL;;CONWAY PETER;;AITKENHEAD WILLIAM;;LEE BRUCE,,https://lens.org/022-131-203-473-43X,Patent Application,yes,0,0,5,5,0,G01V5/226;;G01V5/226,G01V5/00,,0,0,,,,DISCONTINUED
30,CN,A,CN 102099708 A,019-173-812-807-869,2011-06-15,2011,CN 200980127720 A,2009-05-19,US 2009/0044540 W;;US 5444108 P,2008-05-19,X-ray apparatus for inspecting luggage using x-ray sources emitting a plurality of fan-shaped beams,"Embodiments of an Array CT scanning system for x-ray scanning objects (e.g., scanning airline baggage, packages, and cargo) can include a conveyor configured to transport baggage through a tunnel, a bottom mounted x-ray source configured to provide five radial beams through the tunnel, a side mounted x-ray source disposed at a height higher than the conveyor and configured to provide a fan beam through the tunnel, and a plurality of detectors disposed across the arcs of each of the fan beams. An image processing system can be configured to provide 3D type images of a scanned bag as a function of the information received from the detectors. The images can be derived through interpolation of the scan data. An operator can manipulate the image data and partially rotate the bag to discern objects located within. A side tray is provided to allow an operator to remove a suspect bag from an operational flow of bags. Image information can be stored for subsequent review. Multiple scanners can be networked together such that image and passenger information can be transferred to other workstations.",REVEAL IMAGING TECHNOLIGIES IN,ELLENBOGEN MICHAEL P;;RICHARD BIJJANI;;MICHAEL LITCHFIELD;;PETER CONWAY;;WILLIAM AITKENHEAD;;BRUCE LEE,,https://lens.org/019-173-812-807-869,Patent Application,no,3,17,5,5,0,G01V5/226;;G01V5/226,G01V5/00,,0,0,,,,DISCONTINUED
31,US,A1,US 2009/0285353 A1,129-941-168-868-827,2009-11-19,2009,US 46871409 A,2009-05-19,US 46871409 A;;US 5444108 P,2008-05-19,Array CT,"Embodiments of an Array CT scanning system for x-ray scanning objects (e.g., scanning airline baggage, packages, and cargo) can include a conveyor configured to transport baggage through a tunnel, a bottom mounted x-ray source configured to provide five fan beams through the tunnel, a side mounted x-ray source disposed at a height higher than the conveyor and configured to provide a fan beam through the tunnel, and a plurality of detectors disposed across the arcs of each of the fan beams. An image processing system can be configured to provide 3D type images of a scanned bag as a function of the information received from the detectors. The images can be derived through interpolation of the scan data. An operator can manipulate the image data and partially rotate the bag to discern objects located within. A side tray is provided to allow an operator to remove a suspect bag from an operational flow of bags. Image information can be stored for subsequent review. Multiple scanners can be networked together such that image and passenger information can be transferred to other workstations.",REVEAL IMAGING TECHNOLOGIES IN,ELLENBOGEN MICHAEL P;;BIJJANI RICHARD;;LITCHFIELD MICHAEL;;CONWAY PETER;;AITKENHEAD WILLIAM;;LEE BRUCE,REVEAL IMAGING TECHNOLOGIES (2009-06-17),https://lens.org/129-941-168-868-827,Patent Application,yes,8,76,5,5,0,G01V5/226;;G01V5/226,A61B6/00;;G01N23/04,378/9;;378/57,0,0,,,,DISCONTINUED
32,US,B2,US 9784730 B2,129-957-128-332-549,2017-10-10,2017,US 201414222443 A,2014-03-21,US 201414222443 A;;US 201361804033 P,2013-03-21,Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine,"Nanoparticle having a crosslinked chitosan-polyethylene oxide oligomer copolymer coating to which O 6 -benzylguanine is covalently coupled, compositions that include the nanoparticle, and methods for using the nanoparticle to treat brain cancers.",UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;KIEVIT FORREST;;SILBER JOHN R;;STEPHEN ZACHARY;;VEISEH OMID,UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (2014-03-27),https://lens.org/129-957-128-332-549,Granted Patent,yes,47,0,2,2,0,A61K9/00;;A61K31/495;;A61K31/495;;A61K47/6923;;A61K47/6923;;A61K49/0093;;A61K49/0093;;G01N33/5091;;G01N33/5091,A61B5/055;;A61K9/00;;A61K31/495;;A61K49/00;;G01N33/50,,192,185,088-262-951-197-965;;007-087-834-247-157;;011-895-973-571-424;;118-773-146-465-518;;085-210-673-314-119;;091-971-107-194-021;;070-677-896-332-570;;067-551-260-659-154;;003-209-620-180-687;;062-129-077-882-15X;;029-453-900-325-615;;053-083-819-336-733;;000-286-986-959-011;;075-829-768-734-964;;114-756-589-524-345;;009-498-083-230-272;;037-483-866-967-346;;025-988-388-691-282;;037-796-365-534-486;;128-214-487-564-495;;003-849-961-384-35X;;019-024-497-415-689;;026-702-403-737-171;;047-384-424-949-393;;003-191-863-309-112;;011-306-165-996-389;;058-510-434-993-623;;070-727-170-009-371;;002-049-977-040-71X;;159-085-854-543-423;;039-964-981-699-033;;012-675-014-957-841;;050-834-098-066-432;;078-749-765-604-979;;019-065-788-148-50X;;118-159-206-784-554;;062-096-601-946-458;;051-076-259-162-238;;039-721-829-586-003;;000-993-450-752-058;;001-052-226-152-324;;079-349-606-848-507;;027-754-592-221-094;;038-442-198-715-21X;;082-100-684-857-809;;004-545-901-663-019;;141-110-824-694-86X;;040-124-735-362-332;;014-227-634-252-272;;026-693-645-773-51X;;130-797-714-746-782;;129-321-398-314-689;;024-419-743-850-713;;076-985-810-534-474;;070-631-400-706-871;;018-033-421-287-789;;050-765-929-835-567;;030-271-189-211-250;;021-325-853-716-762;;042-053-487-149-918;;067-802-216-339-536;;060-560-913-875-832;;028-505-158-902-435;;129-361-919-666-302;;027-491-289-911-146;;043-699-250-285-742;;019-655-508-001-985;;030-557-429-071-167;;026-402-831-604-792;;045-403-661-453-840;;064-400-365-392-508;;098-180-741-533-899;;022-153-512-298-505;;029-083-713-554-142;;048-319-782-352-971;;061-862-564-428-320;;168-641-193-265-18X;;064-981-520-435-829;;109-526-415-506-273;;040-637-202-663-793;;005-128-838-062-198;;003-502-355-754-995;;063-473-841-268-331;;035-692-293-790-333;;149-905-841-995-437;;047-365-285-601-835;;022-017-822-990-613;;014-286-034-228-340;;028-982-152-302-924;;165-763-310-886-388;;029-674-852-711-798;;007-450-523-990-318;;109-722-968-842-216;;059-164-173-990-121;;070-217-550-786-105;;038-197-896-938-086;;068-683-775-313-217;;031-259-713-342-279;;108-558-669-097-633;;003-464-398-363-332;;095-916-832-224-223;;006-309-964-190-632;;080-122-871-425-598;;150-154-596-880-505;;050-347-691-676-268;;054-930-606-443-966;;129-189-952-168-506;;077-879-730-853-579;;066-627-880-768-425;;027-521-811-732-170;;021-951-366-527-487;;099-570-739-111-152;;053-828-538-943-303;;092-858-479-024-949;;029-083-713-554-142;;054-008-851-807-028;;013-091-141-083-46X;;124-587-008-509-744;;027-613-931-714-40X;;026-747-329-599-725;;054-515-944-382-23X;;076-301-037-764-773;;016-963-216-274-901;;021-208-765-499-814;;000-074-796-407-123;;005-462-784-986-056;;019-532-375-469-348;;023-272-405-705-062;;016-085-044-155-554;;029-251-338-942-396;;037-656-744-900-664;;108-295-188-728-930;;041-373-320-451-433;;097-059-637-710-807;;005-105-635-524-32X;;013-364-541-376-705;;001-351-937-562-434;;039-693-406-061-947;;013-566-586-709-505;;062-707-317-360-281;;004-195-819-489-704;;021-683-206-851-028;;072-371-919-859-350;;009-385-935-427-729;;043-635-448-141-899;;008-852-327-818-500;;013-720-994-628-459;;063-768-034-448-692;;032-086-274-413-031;;073-742-757-256-018;;002-240-030-141-767;;001-259-047-266-893;;044-557-108-637-420;;097-682-291-272-153;;028-467-394-897-784;;035-651-420-313-281;;039-430-779-825-634;;011-768-625-689-731;;014-264-683-268-986;;054-601-126-638-943;;082-834-359-754-649;;082-865-494-451-44X;;102-430-547-461-862;;129-859-172-895-200;;014-636-616-652-691;;021-870-537-824-706;;054-821-923-634-288;;057-641-743-996-83X;;035-288-141-465-174;;005-826-885-809-029;;054-948-356-601-858;;017-246-183-649-969;;048-152-749-258-818;;019-573-942-918-180;;038-683-600-755-496;;066-047-310-493-852;;057-456-863-210-198;;069-079-528-796-093;;041-378-873-525-589;;051-385-636-810-229;;024-153-053-540-43X;;063-420-506-031-362;;108-740-247-130-967;;017-380-528-915-351;;119-106-489-112-148,10.1016/j.polymer.2009.12.003;;pmc2828182;;10.1021/nn900201e;;19673534;;10.1073/pnas.152463399;;pmc130509;;12235356;;17481774;;10.1016/j.addr.2007.03.010;;10.1111/j.1528-1167.2008.01615.x;;pmc2685186;;18479391;;10.1038/nbt1402;;pmc3014085;;18438401;;19047158;;10.1158/0008-5472.can-08-2428;;11118047;;10.1007/3-540-45646-5_12;;10.1016/s0144-8617(97)00006-4;;10.1016/j.ijpharm.2009.05.052;;19501146;;10.1073/pnas.0707461104;;pmc1978218;;17875985;;10.1016/j.pharmthera.2004.08.001;;15500907;;14989470;;10.1111/j.1651-2227.2003.tb00226.x;;14729079;;10.1016/s0939-6411(03)00160-7;;14623938;;10.1177/002215540305101214;;10.1016/j.jconrel.2004.12.019;;15820408;;15719428;;10.1002/mabi.200400140;;12438511;;10.1124/jpet.102.039669;;10.1038/nchembio839;;pmc7097247;;17108989;;1699952;;pmc2116333;;10.1083/jcb.111.5.2129;;10.1016/s0927-7757(00)00633-6;;10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4;;11994126;;10.1046/j.1460-9568.2002.01967.x;;19118021;;10.1158/0008-5472.can-08-2470;;15078992;;10.1158/1535-7163.481.3.4;;10.1021/bc060367e;;17630789;;7599263;;10.1021/bc00032a008;;18437900;;10.1007/978-1-4020-6554-5_14;;10.1002/(sici)1522-2586(199902)9:2<228::aid-jmri12>3.3.co;2-b;;10077018;;10.1002/(sici)1522-2586(199902)9:2<228::aid-jmri12>3.0.co;2-k;;10.1038/nrd3069;;19949390;;19334014;;10.1002/smll.200801647;;pmc2883049;;10565819;;10.1038/nrc1566;;15738981;;10.1016/s0142-9612(02)00445-3;;12527253;;16903692;;10.1021/bm060300u;;pmc2692493;;19115957;;10.1021/mp800134q;;20596545;;pmc2893437;;10.1007/s11671-008-9239-9;;10.1021/nn800507t;;pmc2643365;;19206385;;10.1200/jco.2003.05.063;;12697889;;pmc2843496;;19170493;;10.1021/ja808719p;;10425321;;10.1016/s0168-3659(99)00090-5;;10.1016/j.biomaterials.2004.10.012;;15626447;;15520185;;10.1158/0008-5472.can-04-1813;;10.1038/418244a;;12110901;;3289078;;15809479;;19356738;;10.1016/j.addr.2009.04.001;;10.3109/03639049009114899;;17079050;;10.1016/j.addr.2006.09.008;;16125895;;10.1016/j.tiv.2005.06.034;;10.1016/s0021-9258(17)30580-x;;2229041;;pmc2860962;;20232826;;10.1021/nn100190v;;10.2217/17435889.3.4.495;;pmc2890026;;18694312;;19638572;;10.1158/0008-5472.can-09-1157;;pmc2742601;;22191417;;10.1021/am201649b;;7553637;;10.1016/j.dnarep.2004.02.003;;15135730;;10.1158/1078-0432.ccr-06-1127;;17255284;;10.1158/1535-7163.mct-10-0010;;20457618;;pmc2869471;;15814657;;10.1158/1078-0432.ccr-04-2045;;9816224;;8452662;;10.2165/00002018-199308030-00003;;10.1021/ar2001777;;pmc3219056;;21932809;;9057638;;10.1182/blood.v89.5.1566;;10.1038/nrd2614;;18758474;;10.1074/jbc.m205662200;;12454020;;10.1158/1541-7786.mcr-09-0030;;19609002;;10.1021/nn203430m;;22111891;;pmc3489921;;10.1038/nrclinonc.2010.139;;pmc3065247;;20838415;;pmc3397249;;10.1002/adma.201102313;;21842473;;pmc3192288;;21528865;;10.1021/ar2000277;;20209054;;pmc2832013;;10.1371/annotation/fe02e23b-5168-4586-ba49-d0e0286f4ad3;;10.1371/journal.pone.0009536;;10.2217/17435889.3.5.703;;pmc3407669;;18817471;;22180323;;10.1002/adma.201103458;;10.1002/glia.10083;;12112367;;10.1017/s1740925x06000044;;16520829;;pmc1389710;;10.1017/s17440925x06000044;;17322898;;10.1038/nm1486;;10671613;;10.1148/radiology.214.2.r00fe19568;;10.1038/ncponc1155;;18542116;;8689950;;12231548;;9500473;;pmc3340514;;10.1016/j.bbcan.2011.12.004;;22244911;;9809993;;17638899;;10.1158/0008-5472.can-06-3948;;10.1016/j.addr.2011.01.010;;pmc3132387;;21295093;;10.1016/j.addr.2009.11.002;;19909778;;pmc2827645;;19089837;;pmc2692352;;10.1002/smll.200800646;;pmc19511;;10.1073/pnas.93.24.14164;;8943078;;10.1016/j.jchromb.2005.05.001;;15950555;;17218006;;10.1016/j.biomaterials.2006.12.019;;19053311;;10.1021/bc800278e;;15601762;;10.1073/pnas.0408191101;;pmc539314;;10845554;;10.1023/a:1006760632766;;10.1016/j.jconrel.2007.12.018;;18313785;;20160995;;pmc2756666;;10.1002/adfm.200801844;;10.1038/nrg2006;;17304245;;14678964;;10.1021/ja049195r;;15186157;;17193123;;10.1002/smll.200600009;;16142971;;10.1021/la0503451;;10.1016/s0169-409x(00)00122-8;;11251246;;12164380;;10.1080/10611860290031877;;10.1158/0008-5472.can-04-3921;;15958579;;15584695;;10.1021/cr030441b;;17503854;;10.1021/la062527g;;pmc2695946;;10.1016/j.jconrel.2008.05.003;;18571265;;10.1002/anie.200805998;;19408274;;19422265;;pmc2728206;;10.1021/nl9009793;;10.1021/ja071090b;;17408272;;15626439;;10.1016/j.biomaterials.2004.09.062;;16460717;;10.1016/j.carres.2006.01.008;;10.1007/s12272-001-1191-8;;18449515;;10.2217/17435889.3.5.703;;pmc3407669;;18817471;;17066446;;10.1002/ijc.22296;;17240471;;10.1016/j.jconrel.2006.11.015;;10.1515/cclm.2010.193;;20491597;;10.1200/jco.2005.05.4569;;16877732;;12666906;;10.1021/es0323998;;10.1038/onc.2008.355;;18806831;;10.1189/jlb.0205074;;15923216;;15835712;;10.1021/la035648e;;20188131;;10.1016/j.jconrel.2010.02.024;;18521895;;10.1002/bip.21032;;18363345;;10.1021/bc700464m;;10.1038/nmat2626;;20098433;;20722417;;10.1021/mp100221h;;pmc2997854;;10.1146/annurev.bioeng.9.060906.152025;;17439359;;10.1021/bc060030c;;16704210;;10.1016/j.addr.2009.04.018;;19422869;;11550316;;10.1215/15228517-1-3-232;;10.1215/s1522851798000295;;pmc1920747;;10.1093/neuonc/1.3.232;;10.1602/neurorx.2.1.3;;10.1007/bf03206638;;15717053;;pmc539316;;14993430;;10.1124/mi.3.2.90;;12120094;;10.1038/nrd725;;10.1038/nmat1251;;15568032;;16781003;;10.1016/j.addr.2006.03.007;;9059821;;10.1002/elps.1150180111;;17881203;;10.1016/j.ejpb.2007.02.024;;pmc2570783;;10.1016/j.biomaterials.2008.08.004;;18760470;;12121133;;10.1021/bc010098m;;15265744;;10.1016/j.ab.2004.03.049;;pmc2639552;;19094226;;10.1186/1479-5876-6-80;;10.1021/bc049905i;;15366960;;10.1038/nbt915;;14647331;;pmc5308083;;20059641;;10.1111/j.1365-2796.2009.02189.x;;10.1038/nbt.1602;;20081866;;10.1021/bm0503571;;16398499;;15690125;;10.1007/s11060-004-0890-4;;pmc60126;;11592987;;10.1073/pnas.221450098;;19389434;;10.1016/j.addr.2009.03.007;;pmc2700776;;17254859;;10.1016/j.surneu.2006.08.033;;16371951;;10.1038/nrn1827;;16777679;;10.1080/10611860600650086;;18722754;;10.1016/j.colsurfb.2008.07.004;;19924738;;10.1002/smll.200901513;;pmc2557067;;10.3181/0711-mr-308;;18445774;;10.1016/j.addr.2008.03.018;;18558452;;pmc2702670;;10.1021/ja026501x;;12105897;;10.1007/s10555-007-9064-0;;17415526;;pmc137472;;10.1073/pnas.192581499;;12403826;;pmc3172140;;10.1016/j.addr.2009.03.003;;19328215;;10.1016/j.ejpb.2008.08.021;;18805484;;7214369;;pmc2930137;;10.1016/j.biomaterials.2010.07.016;;20673683;;pmc2709815;;10.1016/j.biomaterials.2008.10.003;;18990439;;10.1021/nl0502569;;15943433;;14649881;;10.1023/a:1026246500788;;16728630;;10.1126/science.1125949;;10.1038/nm0103-123;;12514725;;10.1038/nbt1159;;16244656;;10.1016/0169-409x(95)00033-4;;19180106;;pmc7097568;;10.1038/nrd2742;;pmc319097;;10.1073/pnas.78.1.579;;6941258;;10.1002/jgm.419;;12950071;;10.1021/ja800086u;;18570415;;pmc2621273;;10.1021/nl902789s;;19842673;;9690837;;10.1016/s0142-9612(98)00026-x;;17881202;;10.1016/j.ejpb.2007.08.009;;10.1007/s10856-008-3500-8;;18622769;;15334997;;10.1023/b:jmsm.0000015485.94665.25;;10.1023/b:bmmd.0000013363.77466.63;;15307442;;11922461;;10.1016/s0142-9612(01)00267-8;;10.1016/j.reactfunctpolym.2006.05.006;;18553894;;10.1021/bc800065f,"Teng et al. (Polymer 2010, 51, 639-646).;;Liu et al. (J. Nanomater. 2010, 1-15).;;Agrawal, A., et al., “Functional Delivery of siRNA in Mice Using Dendriworms,” ACS Nano 3(9):2495-2504, Sep. 2009.;;Akerman, M.E., et al., “Nanocrystal Targeting In Vivo,” Proceedings of the National Academy of Sciences USA 99(20):12617-12621, Oct. 2002.;;Akhtar, S., and I. Benter, “Toxicogenomics of Non-Viral Drug Delivery Systems for RNAi: Potential Impact on siRNA-Mediated Gene Silencing Activity and Specificity,” Advanced Drug Delivery Reviews 59(2-3):164-182, Mar. 2007.;;Akhtari, M., et al., “Functionalized Magnetonanoparticles for MRI Diagnosis and Localization in Epilepsy,” Epilepsia 49(8):1419-1430, Aug. 2008.;;Akinc, A., et al., “A Combinatorial Library of Lipid-Like Materials for Delivery for RNAi Therapeutics,” Nature Biotechnology 26(5):561-569, May 2008.;;Aleku, M., et al., “Atu027, A Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression,” Cancer Research 68(23):9788-9798, Dec. 2008.;;Alexiou, C., et al., “Locoregional Cancer Treatment With Magnetic Drug Targeting,” Cancer Research 60(23):6641-6648, Dec. 2000.;;Alexiou, C., et al., “Targeted Tumor Therapy With ‘Magnetic Drug Targeting’: Therapeutic Efficacy of Ferrofluid Bound Mitoxantrone,” Ferrofluids 594:233-251, Nov. 2002.;;Amiji, M.M., “Synthesis of Anionic Poly(ethylene glycol) Derivative for Chitosan Surface Modification in Blood-Contacting Applications,” Carbohydrate Polymers 32(3-4):193-199, Mar.-Apr. 1997.;;Aravindan, L., et al., “Effect of Acyl Chain Length on Transfection Efficiency and Toxicity of Polyethylenimine,” International Journal of Pharmaceutics 378(1-2):201-210, Aug. 2009.;;Bartlett, D.W., et al., “Impact of Tumor-Specific Targeting on the Biodistribution and Efficacy of siRNA Nanoparticles Measured by Multimodality In Vivo Imaging,” Proceedings of the National Academy of Sciences USA 104(39):15549-15554, Sep. 2007.;;Begley, D.J., “Delivery of Therapeutic Agents to the Central Nervous System: The Problems and the Possibilities,” Pharmacology & Therapeutics 104(1):29-45, Oct. 2004.;;Begley, D.J., “Understanding and Circumventing the Blood-Brain Barrier,” Acta Paediatrica 92(Suppl S443):83-91, Dec. 2003.;;Berger, J. et al., “Structure and Interactions in Chitosan Hydrogels Formed by Complexation or Aggregation for Biomedical Applications,” European Journal of Pharmaceutics and Biopharmaceutics 57(1):35-52, Jan. 2004.;;Berlier, J.E., et al., “Quantitative Comparison of Long-Wavelength Alexa Fluor Dyes to Cy Dyes: Fluorescence of the Dyes and Their Bioconjugates,” Journal of Histochemistry & Cytochemistry 51(12):1699-1712, Dec. 2003.;;Bhattarai, N., et al., “PEG-Grafted Chitosan as an Injectable Thermosensitive Hydrogel for Sustained Protein Release,” Journal of Controlled Release 103(3):609-624, Apr. 2005.;;Bhattarai, N., et al., “PEG-Grafted Chitosan as an Injectable Thermoreversible Hydrogel,” Macromolecular Bioscience 5(2):107-111, Feb. 2005.;;Brigger, I., et al., “Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting,” Journal of Pharmacology and Experimental Therapeutics 303(3):928-936, Dec. 2002.;;Bumcrot, D., et al., “RNAi Therapeutics: A Potential New Class of Pharmaceutical Drugs,” Nature Chemical Biology 2(12):711-719, Dec. 2006.;;Burgess, W.H., et al., “Possible Dissociation of the Heparin-Binding and Mitogenic Activities of Heparin-Binding (Acidic Fibroblast) Growth Factor-1 From Its Receptor-Binding Activities by Site-Directed Mutagenesis of a Single Lysine Residue,” Journal of Cell Biology 111(5 Pt. 1):2129-2138, Nov. 1990.;;Butterworth, M.D., et al., “Preparation of Ultrafine Silica- and PEG-Coated Magnetite Particles,” Colloids and Surfaces A: Physicochemical and Engineering Aspects 179(1):93-102, Apr. 2001.;;Calvo, P., et al., “Novel Hydrophilic Chitosan-Polyethylene Oxide Nanoparticles as Protein Carriers,” Journal of Applied Polymer Science 63(1):125-132, Jan. 1997.;;Calvo, P., et al., “Quantification and Localization of PEGylated Polycyanoacrylate Nanoparticles in Brain and Spinal Cord During Experimental Allergic Encephalomyelitis in the Rat,” European Journal of Neuroscience 15(8):1317-1326, Apr. 2002.;;Chiche, J., et al., “Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis Through the Regulation of the Intracellular pH,” Cancer Research 69(1):358-368, Jan. 2009.;;Citrin, D., et al., “In Vivo Tumor Imaging in Mice With Near-Infrared Labeled Endostatin,” Molecular Cancer Therapeutics 3(4):481-488, Apr. 2004.;;Derfus, M., et al., “Targeted Quantum Dot Conjugates for siRNA Delivery,” Bioconjugate Chemistry 18(5):1391-1396, Sep.-Oct. 2007.;;Devineni, D., et al., “Preparation and In Vitro Evaluation of Magnetic Microsphere-Methotrexate Conjugate Drug Delivery Systems,” Bioconjugate Chemistry 6(2):203-210, Mar.-Apr. 1995.;;Dykxhoorn, D.M., et al., “RNA Interference and Cancer: Endogenous Pathways and Therapeutic Approaches,” Advances in Experimental Medicine and Biology 615:299-329, 2008.;;Enochs, W.S., et al., “Improved Delineation of Human Brain Tumors on MR Images Using a Long-Circulating, Superparamagnetic Iron Oxide Agent,” Journal of Magnetic Resonance Imaging 9(2):228-232, Feb. 1999.;;Extance, A., “Targeting RNA: An Emerging Hope for Treating Muscular Dystrophy,” Nature Reviews Drug Discovery 8(12):917-918, Dec. 2009.;;Fang, C., et al., “Functionalized Nanoparticles With Long-Term Stability in Biological Media,” Small 5(14):1637-1641, Jul. 2009.;;Fenart, L., et al., “Evaluation of Effect of Charge and Lipid Coating on Ability of 60-nm Nanoparticles to Cross an In Vitro Model of the Blood-Brain Barrier,” Journal of Pharmacology and Experimental Therapeutics 291(3):1017-1022, Dec. 1999.;;Ferrari, M., “Cancer Nanotechnology: Opportunities and Challenges,” Nature Reviews Cancer 5(3):161-171, Mar. 2005.;;Fischer, D., et al., “In Vitro Cytotoxicity Testing of Polycations: Influence of Polymer Structure on Cell Viability and Hemolysis,” Biomaterials 24(7):1121-1131, Mar. 2003.;;Gabrielson, N.P., and D.W. Pack, “Acetylation of Polyethylenimine Enhances Gene Delivery Via Weakened Polymer/DNA Interactions,” Biomacromolecules 7(8):2427-2435, Aug. 2006.;;Gao, K., and L. Huang, “Nonviral Methods for siRNA Delivery,” Molecular Pharmaceutics 6(3):651-658, May-Jun. 2009.;;Ge, Y., et al., “Fluorescence Modified Chitosan-Coated Magnetic Nanoparticles for High-Efficient Cellular Imaging,” Nanoscale Research Letters 4(4):287-295, Jan. 2009.;;Ghosh, P.S., et al., “Efficient Gene Delivery Vectors by Tuning the Surface Charge Density of Amino Acid-Functionalized Gold Nanoparticles,” ACS Nano 2(11):2213-2218, Nov. 2008.;;Giese, A., et al., “Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment,” Journal of Clinical Oncology 21(8):1624-1636, Apr. 2003.;;Giljohann, D.A., et al., “Gene Regulation With Polyvalent siRNA-Nanoparticle Conjugates,” Journal of the American Chemical Society 131(6):2072-2073, Feb. 2009.;;Godbey, W.I., et al., “Poly(ethylenimine) and Its Role in Gene Delivery,” Journal of Controlled Release 60(2-3):149-160, Aug. 1999.;;Gupta, A.K., and M. Gupta, “Synthesis and Surface Engineering of Iron Oxide Nanoparticles for Biomedical Applications,” Biomaterials 26(18):3995-4021, Jun. 2005.;;Hallahan, R., et al., “The SmoA1 Mouse Model Reveals That Notch Signaling is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas,” Cancer Research 64(21):7794-7800, Nov. 2004.;;Hannon, G.J., “RNA Interference,” Nature 418(6894):244-251, Jul. 2002.;;Hesselink, J.R., and G.A. Press, “MR Contrast Enhancement of Intracranial Lesions With Gd-DTPA,” Radiologic clinics of North America 26(4):873-887, Jul. 1988.;;Hockaday et al., “Imaging Glioma Extent With 131I-TM-601,” Journal of Nuclear Medicine 46(4):580-586, Apr. 2005.;;Howard, K.A., “Delivery of RNA Interference Therapeutics Using Polycation-Based Nanoparticles,” Advanced Drug Delivery Reviews 61(9):710-720, Jul. 2009.;;Hung, C.T., et al., “Formulation and Characterization of Magnetic Polyglutaraldehyde Nanoparticles as Carriers for Poly-1-Lysine-Methotrexate,” Drug Development and Industrial Pharmacy 16(3):509-521, Jan. 1990.;;Hunter, A.C., “Molecular Hurdles in Polyfectin Design and Mechanistic Background to Polycation Induced Cytotoxicity,” Advanced Drug Delivery Reviews 58(14):1523-1531, Dec. 2006.;;Hussain, S.M., et al., “In Vitro Toxicity of Nanoparticles in BRL 3A Rat Liver Cells,” Toxicology In Vitro 19(7):975-983, Oct. 2005.;;Gunn, J., et al., “Superparamagnetic Nanoparticle-Bound Chlorotoxin for Brain Tumor Imaging,” in D.R. Baer and C.T. Campbell (eds.), Joint Institute for Nanoscience Annual Report, 2004, pp. 2.62-2.67, Jul. 2005.;;Feener, E.P., et al., “Cleavage of Disulfide Bonds in Endocytosed Macromolecules. A Processing Not Associated With Lysosomes or Endosomes,” Journal of Biological Chemistry 265(31):18780-18785, Nov. 1990.;;Sun, C., et al., “PEG-Mediated Synthesis of Highly Dispersive Multifunctional Superparamagnetic Nanoparticles: Their Physicochemical Properties and Function In Vivo,” ACS Nano 4(4):2402-2410, Apr. 2010.;;Sun, C., et al., “Tumor-Targeted Drug Delivery and MRI Contrast Enhancement by Chlorotoxin-Conjugated Iron Oxide Nanoparticles,” Nanomedicine (London) 3(4):495-505, Aug. 2008 (Author Manuscript provided, PMCID: PMC2890026, available in PMC Jun. 22, 2010, 16 pages).;;Veiseh, O., et al., “Specific Targeting of Brain Tumors With an Optical/MR Imaging Nanoprobe Across the Blood Brain Barrier,” Cancer Research 69(15):6200-6207, Aug. 2009 (Author Manuscript provided, PMCID:PMC2742601, available in PMC Aug. 1, 2010, 17 pages).;;Zhou, L., et al., “Facile One-Pot Synthesis of Iron Oxide Nanoparticles Cross-Linked Magnetic Poly(vinyl alcohol) Gel Beads for Drug Delivery,” ACS Applied Materials & Interfaces 4(1):192-199, Jan. 2012.;;Berg, S.L., et al., “Plasma and Cerebrospinal Fluid Pharmacokinetics of O6-Benzylguanine and Time Course of Peripheral Blood Mononuclear Cell O6-Methylguanine-DNA Methyltransferase Inhibition in the Nonhuman Primate,” Cancer Research 55(20):4606-4610, Oct. 1995.;;Blank, A., et al., “The Werner Syndrome Protein Confers Resistance to the DNA Lesions N3-Methyladenine and O6-Methylguanine: Implications for WRN Function,” DNA Repair 3(6):629-638, Jun. 2004.;;Bobola, M.S., et al., “Human Glioma Cell Sensitivity to the Sequence-Specific Alkylating Agent Methyl-Lexitropsin,” Clinical Cancer Research 13(2 Pt. 1):612-620, Jan. 2007.;;Bobola, M.S., et al., “Minimally Cytotoxic Doses of Temozolomide Produce Radiosensitization in Human Glioblastoma Cells Regardless of MGMT Expression,” Molecular Cancer Therapeutics 9(5):1208-1218, May 2010. (Author Manuscript provided, PMCID: PMC2869471, available in PMC May 1, 2011, 19 pages).;;Bobola, M.S., et al., “O6-Methylguanine-DNA Methyltransferase, O6-Benzylguanine, and Resistance to Clinical Alkylators in Pediatric Primary Brain Tumor Cell Lines,” Clinical Cancer Research 11(7):2747-2755, Apr. 2005.;;Bobola, M.S., et al., “Role of O6-Methylguanine-DNA Methyltransferase in Resistance of Human Brain Tumor Cell Lines to the Clinically Relevant Methylating Agents Temozolomide and Streptozotocin,” Clinical Cancer Research 2(4):735-741, Apr. 1996.;;Bodensteiner, D.C., and G.C. Doolittle, “Adverse Haematological Complications of Anticancer Drugs: Clinical Presentation, Management and Avoidance,” Drug Safety 8(3):213-224, Mar. 1993.;;Caldorera-Moore, M.E., et al., “Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery Carriers,” Accounts of Chemical Research 44(10):1061-1070, Oct. 2011.;;Chinnasamy, N., et al., “O6-Benzylguanine Potentiates the In Vivo Toxicity and Clastogenicity of Temozolomide and BCNU in Mouse Bone Marrow,” Blood 89(5):1566-1573, Mar. 1997.;;Davis, M.E., et al., “Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer,” Nature Reviews: Drug Discovery 7(9):771-782, Sep. 2008.;;Deshane, J., et al., “Chlorotoxin Inhibits Glioma Cell Invasion Via Matrix Metalloproteinase-2,” Journal of Biological Chemistry 278(6):4135-4144, Feb. 2003.;;Feener, E.P., et al., “Cleavage of Disulfide Bonds in Endocytosed Macromolecules: A Processing Not Associated With Lysosomes or Endosomes,” Journal of Biological Chemistry 265(31):18780-18785, Nov. 1990.;;Frosina, G., “DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy,” Molecular Cancer Research 7(7):989-999, Jul. 2009.;;Ge, J., et al., “Drug Release From Electric-Field-Responsive Nanoparticles,” ACS Nano 6(1):227-233, Jan. 2012.;;Jain, R.K., and T. Stylianopoulos, “Delivering Nanomedicine to Solid Tumors,” Nature Review: Clinical Oncology 7(11):653-664, Nov. 2010. (Author Manuscript provided, PMCID: PMC3065247, available in PMC Nov. 1, 2011, 24 pages.).;;Kievit, F.M., and M. Zhang, “Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers,” Advanced Materials 23(36):H217-H247, Sep. 2011. (Author Manuscript provided, PMCID: PMC3397249, available in PMC Sep. 22, 2012, 58 pages.).;;Kievit, F.M., and M. Zhang, “Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy,” Accounts of Chemical Research 44(10):853-862, Oct. 2011. (Author Manuscript provided, PMCID: PMC3192288, available in PMC Oct. 18, 2012, 19 pages.).;;Lee, M.J.-E., et al., “Rapid Pharmacokinetic and Biodistribution Studies Using Chlorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method,” PLoS One 5(3):e9536, Mar. 2010.;;Longmire, M., et al., “Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats,” Nanomedicine (London) 3(5):703-717, Oct. 2008. (Author Manuscript provided, PMCID: PMC3407669, available in PMC Jul. 29, 2012, 21 pages.).;;Luo, Z., et al., “Redox-Responsive Molecular Nanoreservoirs for Controlled Intracellular Anticancer Drug Delivery Based on Magnetic Nanoparticles,” Advanced Materials 24(3):431-435, Jan. 2012.;;Lyons, S.A., et al., “Chlorotoxin, a Scorpion-Derived Peptide, Specifically Binds to Gliomas and Tumors of Neuroectodermal Origin,” GLIA 39(2):162-173, Aug. 2002.;;McFerrin, M.B., and H. Sontheimer, “A Role for Ion Channels in Glioma Cell Invasion,” Neuron Glia Biology 2(1):39-49, Feb. 2006. (Author Manuscript provided, PMCID: PMC1389710, available in PMC Mar. 6, 2006, 18 pages.).;;Medarova, Z., et al., “In Vivo Imaging of siRNA Delivery and Silencing in Tumors,” Nature Medicine 13(3):372-377, Mar. 2007.;;Moore, A., et al., “Tumoral Distribution of Long-Circulating Dextran-Coated Iron Oxide Nanoparticles in a Rodent Model,” Radiology 214(2):568-574, Feb. 2000.;;Mrugala, M.M., and M.C. Chamberlain, “Mechanisms of Disease: Temozolomide and Glioblastoma—Look to the Future,” Nature Clinical Practice: Oncology 5(8):476-486, Aug. 2008.;;Patil, R., et al., “Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic Acid),” Pharmaceutical Research 27(11):2317-2329, Nov. 2010. (Author Manuscript provided, PMCID: PMC2952070, available in PMC May 1, 2011, 25 pages.).;;Roy, S.K., et al., “Pharmacokinetics of O6-Benzylguanine in Rats and Its Metabolism by Rat Liver Microsomes,” Drug Metabolism and Disposition 23(12):1394-1399, Dec. 1995.;;Silber, J.R., et al., “The Apurinic/Apyrimidinic Endonuclease Activity of Ape1/Ref-1 Contributes to Human Glioma Cell Resistance to Alkylating Agents and is Elevated by Oxidative Stress,” Clinical Cancer Research 8(9):3008-3018, Sep. 2002.;;Silber, J.R., et al., “O6-Methylguanine-DNA Methyltransferase Activity in Adult Gliomas: Relation to Patient and Tumor Characteristics,” Cancer Research 58(5):1068-1073, Mar. 1998.;;Silber, J.R., et al., “O6-Methylguanine-DNA Methyltransferase in Glioma Therapy: Promise and Problems,” Biochimica et Biophysica Acta 1826(1):71-82, Aug. 2012.;;Soroceanu, L., et al., “Use of Chlorotoxin for Targeting of Primary Brain Tumors,” Cancer Research 58(21):4871-4879, Nov. 1998.;;Sun, C., et al., “Tumor-Targeted Drug Delivery and MRI Contrast Enhancement by Chlorotoxin-Conjugated Iron Oxide Nanoparticles,” Nanomedicine (London) 3(4):495-505, Aug. 2008. (Author Manuscript provided, PMCID: PMC2890026, available in PMC Jun. 22, 2010, 16 pages.).;;Veiseh, M., et al., “Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci,” Cancer Research 67(14):6882-6888, Jul. 2007.;;Veiseh, O., et al., “Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine,” 63(8):582-596, Jul. 2011. (Author Manuscript provided, PMCID: PMC3132387, available in PMC Jul. 18, 2012, 34 pages.).;;Veiseh, O., et al., “Design and Fabrication of Magnetic Nanoparticles for Targeted Drug Delivery and Imaging,” Advanced Drug Delivery Reviews 62(3):284-304, Mar. 2010. (Author Manuscript provided, PMCID: PMC2827645, available in PMC Mar. 8, 2011, 42 pages.).;;Veiseh, O., et al., “Inhibition of Tumor Cell Invasion With Chlorotoxin-Bound Superparamagnetic Nanoparticles,” Small 5(2):256-264, Feb. 2009. (Author Manuscript provided, PMCID: PMC2692352, available in PMC Feb. 1, 2010, 19 pages.).;;Veiseh, O., et al., “Specific Targeting of Brain Tumors With an Optical/MR Imaging Nanoprobe Across the Blood Brain Barrier,” Cancer Research 69(15):6200-6207, Aug. 2009. (Author Manuscript provided, PMCID: PMC2742601, available in PMC Aug. 1, 2010, 17 pages.).;;Huwyler, J., et al., “Brain Drug Delivery of Small Molecules Using Immunoliposomes,” Proceedings of the National Academy of Sciences USA 93(24):14164-14169, Nov. 1996.;;Islam, M.T., et al., “HPLC Analysis of PAMAM Dendrimer Based Multifunctional Devices,” Journal of Chromatography B 822(1-2):21-26, Aug. 2005.;;Jeong, J.H., et al., “Reducible Poly(amido ethylenimine) Directed to Enhance RNA Interference,” Biomaterials 28(10):1912-1917, Apr. 2007.;;Jeong, J.H., et al., “siRNA Conjugate Delivery Systems,” Bioconjugate Chemistry 20(1):5-14, Nov. 2008.;;Jiang, T., et al., “Tumor Imaging by Means of Proteolytic Activation of Cell-Penetrating Peptides,” Proceedings of the National Academy of Sciences USA 101(51):17867-17872, Dec. 2004.;;Kachra, Z., et al., “Expression of Matrix Metalloproteinases and Their Inhibitors in Human Brain Tumors,” Clinical and Experimental Metastasis 17(7):555-566, 1999.;;Kaur, I.P., et al., “Potential of Solid Lipid Nanoparticles in Brain Targeting,” Journal of Controlled Release 127(2):97-109, Apr. 2008.;;Kievit, F.M., et al., “PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection,” Advanced Functional Materials 19(14):2244-2251, Jul. 2009.;;Kim, D.H., and J.J. Rossi, “Strategies for Silencing Human Disease Using RNA Interference,” Nature Reviews Genetics 8(3):173-184, Mar. 2007.;;Kircher, M.F., et al., “A Multimodal Nanoparticle for Preoperative Magnetic Resonance Imaging and Intraoperative Optical Brain Tumor Delineation,” Cancer Research 63(23):8122-8125, Dec. 2003.;;Kohler, N., et al., “A Bifunctional Poly(ethylene glycol) Silane Immobilized on Metallic Oxide-Based Nanoparticles for Conjugation With Cell Targeting Agents,” Journal of the American Chemical Society 126(23):7206-7211, Jun. 2004.;;Kohler, N., et al., “Methotrexate-Immobilized Poly(ethylene glycol) Magnetic Nanoparticles for MR Imaging and Drug Delivery,” Small 2(6):785-792, Jun. 2006.;;Kohler, N., et al., “Methotrexate-Modified Superparamagnetic Nanoparticles and Their Intracellular Uptake Into Human Cancer Cells,” Langmuir 21(19):8858-8864, Sep. 2005.;;Kreuter, J., “Nanoparticulate Systems for Brain Delivery of Drugs,” Advanced Drug Delivery Reviews 47(1):65-81, Mar. 2001.;;Kreuter, J., et al., “Apolipoprotein-Mediated Transport of Nanoparticle-Bound Drugs Across the Blood-Brain Barrier,” Journal of Drug Targeting 10(4):317-325, Jun. 2002.;;Kukowska-Latallo, J.F., et al., “Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer,” Cancer Research 65(12):5317-5324, Jun. 2005.;;Kumar, M., et al., “Chitosan Chemistry and Pharmaceutical Perspectives,” Chemical Reviews 104(12):6017-6084, Dec. 2004.;;Lai, J.J. et al., “Dual Magnetic-/Temperature-Responsive Nanoparticles for Microfluidic Separations and Assays,” Langmuir 23(13):7385-7391, Jun. 2007.;;Lazar, E., et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities,” Molecular and Cellular Biology 8(3):1247-1252, Mar. 1988.;;Lee, E.S., et al., “Recent Progress in Tumor pH Targeting Nanotechnology,” Journal of Controlled Release 132(3):164-170, Dec. 2008.;;Lee, J.H., et al., “All-in-One Target-Cell-Specific Magnetic Nanoparticles for Simultaneous Molecular Imaging and siRNA Delivery,” Angewandte Chemie International Edition 48(23):4174-4179, May 2009.;;Lee, J.S., et al. “Gold, Poly(beta-amino ester) Nanoparticles for Small Interfering RNA Delivery,” Nano Letters 9(6):2402-2406, Jun. 2009.;;Lee, Y., et al., “A Protein Nanocarrier From Charge-Conversion Polymer in Response to Endosomal pH,” Journal of the American Chemical Society 129(17):5362-5363, May 2007.;;Li, Z. et al., “Chitosan-Alginate Hybrid Scaffolds for Bone Tissue Engineering,” Biomaterials 26(18):3919-3928, Jun. 2005.;;Liu, D., et al., “Determination of the Degree of Acetylation of Chitosan by UV Spectrophotometry Using Dual Standards,” Carbohydrate Research 341(6):782-785, May 2006.;;Liu, M., et al., “Pharmacokinetics and Biodistribution of Surface Modification Polymeric Nanoparticles,” Archives of Pharmacal Research 31(4):547-554, Apr. 2008.;;Longmire, M., et al., “Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats,” Nanomedicine 3(5):703-717, Oct. 2008.;;Lu, W., et al., “Aclarubicin-Loaded Cationic Albumin-Conjugated Pegylated Nanoparticle for Glioma Chemotherapy in Rats,” International Journal of Cancer 120(2):420-431, Jan. 2007.;;Lu, W., et al., “Brain Delivery Property and Accelerated Blood Clearance of Cationic Albumin Conjugated Pegylated Nanoparticle,” Journal of Controlled Release 118(1):38-53, Mar. 2007.;;Madabhushi, A., et al., “Integrated Diagnostics: A Conceptual Framework With Examples,” Clinical Chemistry and Laboratory Medicine 48(7):989-998, Jul. 2010.;;Mamelak, A.N., et al., “Phase I Single-Dose Study of Intracavitary-Administered Iodine-131-TM-601 in Adults With Recurrent High-Grade Glioma,” Journal of Clinical Oncology 24(22):3644-3650, Aug. 2006.;;Masciangioli, T., and W.X. Zhang, “Environmental Technologies at the Nanoscale,” Environmental Science & Technology 37(5):102A-108A, Mar. 2003.;;Mashima, T., et al., “Promotion of Glioma Cell Survival by acyl-CoA Synthetase 5 Under Extracellular Acidosis Conditions,” Oncogene 28(1):9-19, Jan. 2009.;;McNeil, S.E., “Nanotechnology for the Biologist,” Journal of Leukocyte Biology 78(3):585-594, Sep. 2005.;;Mikhaylova, M., et al., “Superparamagnetism of Magnetite Nanoparticles: DEPENDENCE on Surface Modification,” Langmuir 20(6):2472-2477, Mar. 2004.;;Min, K.H., et al., “Tumoral Acidic pH-Responsive MPEG-Poly(beta-amino ester) Polymeric Micelles for Cancer Targeting Therapy,” Journal of Controlled Release 144(2):259-266, Jun. 2010.;;Mok, H., and T.G. Park, “Self-Crosslinked and Reducible Fusogenic Peptides for Intracellular Delivery of siRNA,” Biopolymers 89(10):881-888, Oct. 2008.;;Mok, H., et al., “Enhanced Intracellular Delivery of Quantum Dot and Adenovirus Nanoparticles Triggered by Acidic pH Via Surface Charge Reversal,” Bioconjugate Chemistry 19(4):797-801, Apr. 2008.;;Mok, H., et al., “Multimeric Small Interfering Ribonucleic Acid for Highly Efficient Sequence-Specific Gene Silencing,” Nature Materials 9(3):272-278, Mar. 2010.;;Mok, H., et al., “pH-Sensitive siRNA Nanovector for Targeted Gene Silencing and Cytotoxic Effect in Cancer Cells,” Molecular Pharmaceutics 7(6):1930-1939, Aug. 2010.;;Nie, S., et al., “Nanotechnology Applications in Cancer,” Annual Review of Biomedical Engineering 9:257-288, Aug. 2007.;;Oh, I.K., et al., “Folate Immobilized and PEGylated Adenovirus for Retargeting to Tumor Cells,” Bioconjugate Chemistry 17(3):721-727, May-Jun. 2006.;;Oh, Y.K., and T.G. Park, “siRNA Delivery Systems for Cancer Treatment,” Advanced Drug Delivery Reviews 61(10):850-862, Aug. 2009.;;Packer, R.J., et al., “Medulloblastoma: Clinical and Biologic Aspects,” Neuro-Oncology 1(3):232-250, Jul. 1999.;;Pardridge, W.M., “The Blood-Brain Barrier: Bottleneck in Brain Drug Development,” NeuroRx 2(1):3-14, Jan. 2005.;;Pardridge, W.M., “Blood-Brain Barrier Drug Targeting: The Future of Brain Drug Development,” Molecular Interventions 3(2):90-105, Mar. 2003.;;Pardridge, W.M., “Drug and Gene Targeting to the Brain With Molecular Trojan Horses,” Nature Reviews Drug Discovery 1(2):131-139, Feb. 2002.;;Park, J., et al., “Ultra-Large-Scale Syntheses of Monodisperse Nanocrystals,” Nature Materials 3(12):891-895, Dec. 2004.;;Park, T.G., et al., “Current Status of Polymeric Gene Delivery Systems,” Advanced Drug Delivery Reviews 58(4):467-486, Jul. 2006.;;Pernodet, N., et al., “Pore Size of Agarose Gels by Atomic Force Microscopy,” Electrophoresis 18(1):55-58, Jan. 1997.;;Petri-Fink, A., et al., “Effect of Cell Media on Polymer Coated Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Colloidal Stability, Cytotoxicity, and Cellular Uptake Studies,” Eurorpean Journal of Pharmaceutics and Biopharmaceutics 68(1):129-137, Jan. 2008.;;Rao, K.S., et al., “TAT-Conjugated Nanoparticles for the CNS Delivery of Anti-HIV Drugs,” Biomaterials 29(33):4429-4438, Nov. 2008.;;Riebeseel, K., et al., “Polyethylene Glycol Conjugates of Methotrexate Varying in Their Molecular Weight From MW 750 to MW 40000: Synthesis, Characterization, and Structure-Activity Relationships In Vitro and In Vivo,” Bioconjugate Chemistry 13(4):773-785, Jul.-Aug. 2002.;;Riemer, J., et al., “Colorimetric Ferrozine-Based Assay for the Quantitation of Iron in Cultured Cells,” Analytical Biochemistry 331(2):370-375, Aug. 2004.;;Sarin, H., et al., “Effective Transvascular Delivery of Nanoparticles Across the Blood-Brain Tumor Barrier Into Malignant Glioma Cells,” Journal of Translational Medicine 6:80, Dec. 2008, 15 pages.;;Schellenberger, E.A., et al., “Magneto/Optical Annexin V, a Multimodal Protein,” Bioconjugate Chemistry 15(5):1062-1067, Sep.-Oct. 2004.;;Scherer, I.J., and J.J. Rossi, “Approaches for the Sequence-Specific Knockdown of mRNA,” Nature Biotechnology 21(12):1457-1465, Dec. 2003.;;Schroeder, A., et al., “Lipid-Based Nano-Therapeutics for siRNA Delivery,” Journal of Internal Medicine 267(1):9-21, Jan. 2010.;;Semple, S.C., et al., “Rational Design of Cationic Lipids for siRNA Delivery,” Nature Biotechnology 28(2):172-176, Feb. 2010.;;Sethuraman, V.A., et al., “pH-Responsive Sulfonamide/PEI System for Tumor Specific Gene Delivery: An In Vitro Study,” Biomacromolecules 7(1):64-70, Jan. 2006.;;Shen, S., et al., “Radiation Dosimetry of 131I-Chlorotoxin for Targeted Radiotherapy in Glioma-Bearing Mice,” Journal of Neuro-Oncology 71(2):113-119, Jan. 2005.;;Shi, N., et al., “Brain-Specific Expression of an Exogenous Gene After I.V. Administration,” Proceedings of the National Academy of Sciences USA 98(22):12754-12759, Oct. 2001.;;Shubayev, V.I., et al., “Magnetic Nanoparticles for Theragnostics,” Advanced Drug Delivery Reviews 61(6):467-477, Jun. 2009.;;Silva, G.A., “Nanotechnology Approaches for Drug and Small Molecule Delivery Across the Blood Brain Barrier,” Surgical Neurology 67(2):113-116, Feb. 2007.;;Silva, G.A., “Neuroscience Nanotechnology: Progress, Opportunities and Challenges,” Nature Reviews Neuroscience 7(1):65-74, Jan. 2006.;;Smith, M.W., and M. Gumbleton, “Endocytosis at the Blood-Brain Barrier: From Basic Understanding to Drug Delivery Strategies,” Journal of Drug Targeting 14(4):191-214, May 2006.;;Sonavane, G., et al., “Biodistribution of Colloidal Gold Nanoparticles After Intravenous Administration: Effect of Particle Size,” Colloids and Surfaces B: Biointerfaces 66(2):274-280, Oct. 2008.;;Song, W.J., et al., “Gold Nanoparticles Capped With Polyethyleneimine for Enhanced siRNA Delivery,” Small 6(2):239-246, Jan. 2010.;;Sontheimer, H., “An Unexpected Role for Ion Channels in Brain Tumor Metastasis,” Experimental Biology and Medicine 233(7):779-791, Jul. 2008.;;Sun, C., et al., “Magnetic Nanoparticles in MR Imaging and Drug Delivery,” Advanced Drug Delivery Reviews 60(11):1252-1265, Aug. 2008.;;Sun, S., and H. Zeng, “Size-Controlled Synthesis of Magnetite Nanoparticles,” Journal of the American Chemical Society 124(28):8204-8205, Jun. 2002.;;Swietach, P., et al., “Regulation of Tumor pH and the Role of Carbonic Anhydrase 9,” Cancer Metastasis Reviews 26(2):299-310, Jun. 2007.;;Thomas, M., and A.M. Klibanov, “Enhancing Polyethylenimine's Delivery of Plasmid DNA Into Mammalian Cells,” Proceedings of the National Academy of Sciences USA 99(23):14640-14645, Nov. 2002.;;Tseng, Y.C., et al., “Lipid-Based Systemic Delivery of siRNA,” Advanced Drug Delivery Reviews 61(9):721-731, Jul. 2009.;;Ulbrich, K., et al., “Transferrin- and Transferrin-Receptor-Antibody-Modified Nanoparticles Enable Drug Delivery Across the Blood-Brain Barrier (BBB),” European Journal of Pharamecutics and Biopharmaceutics 71(2):251-256, Feb. 2009.;;Vaupel, P.W., et al., “Heterogeneous Oxygen Partial Pressure and pH Distribution in C3H Mouse Mammary Adenocarcinoma,” Cancer Research 41(5):2008-2013, May 1981.;;Veiseh, O., et al., “Chlorotoxin Bound Magnetic Nanovector Tailored for Cancer Cell Targeting, Imaging, and siRNA Delivery,” Biomaterials 31(31):8032-8042, Nov. 2010.;;Veiseh, O., et al., “A Ligand-Mediated Nanovector for Targeted Gene Delivery and Transfection in Cancer Cells,” Biomaterials 30(4):649-657, Feb. 2009.;;Veiseh, O., et al., “Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas,” Nano Letters 5(6):1003-1008, Jun. 2005.;;Weaver, M., and D.W. Laske, “Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas,” Journal of Neuro-Oncology 65(1):3-13, Oct. 2003.;;Weissleder, R., “Molecular Imaging in Cancer,” Science 312(5777):1168-1171, May 2006.;;Weissleder, R., and V. Ntziachristos, “Shedding Light Onto Live Molecular Targets,” Nature Medicine 9(1):123-128, Jan. 2003.;;Weissleder, R., et al., “Cell-Specific Targeting of Nanoparticles by Multivalent Attachment of Small Molecules,” Nature Biotechnology 23(11):1418-1423, Nov. 2005.;;Weissleder, R., et al., “Long-Circulating Iron Oxides for MR Imaging,” Advanced Drug Delivery Reviews 16(2-3):321-334, Sep. 1995.;;Whitehead, K.A., et al., “Knocking Down Barriers: Advances in siRNA Delivery,” Nature Reviews Drug Discovery 8(2):129-138, Feb. 2009.;;Widder, K.J., et al., “Tumor Remission in Yoshida Sarcoma-Bearing Rats by Selective Targeting of Magnetic Albumin Microspheres Containing Doxorubicin,” Proceedings of the National Academy of Sciences USA 78(1):579-581, Jan. 1981.;;Xiang, J.J., et al., “IONP-PLL: A Novel Non-Viral Vector for Efficient Gene Delivery,” Journal of Gene Medicine 5(9):803-817, Sep. 2003.;;Yezhelyev, M.V., et al., “Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging,” Journal of the American Chemical Society 130(28):9006-9012, Jul. 2008.;;You, J.O., and D.T. Auguste, “Nanocarrier Cross-Linking Density and pH Sensitivity Regulate Intracellular Gene Transfer,” Nano Letters 9(12):4467-4473, Dec. 2009.;;Zhang, M.Q., et al., “Proteins and Cells on PEG Immobilized Silicon Surfaces,” Biomaterials 19(10):953-960, May 1998.;;Zhang, X., et al., “Nasal Absorption Enhancement of Insulin Using PEG-Grafted Chitosan Nanoparticles,” European Journal of Pharmaceutics and Biopharmaceutics 68(3):526-534, Mar. 2008. et al.",ACTIVE
33,WO,A1,WO 2022/076545 A1,106-676-285-768-228,2022-04-14,2022,US 2021/0053753 W,2021-10-06,US 202063089403 P,2020-10-08,IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA,"A nanoparticle for targeted siRNA delivery comprising an iron oxide core and a chitosan-polyethylene glycol-polyethylenimine copolymer coating surrounding the core, chlorotoxin covalently coupled to the coating, and an siRNA reversibly associated to the coating by non-covalent interaction. Methods for making the nanoparticle and methods for using the nanoparticle to suppress the expression of O 6 -methylguanine-DNA methyltransferase (MGMT), treating brain cancer, and killing cancer stem cells.",UNIV WASHINGTON,ZHANG MIQIN;;ELLENBOGEN RICHARD;;WANG KUI;;KIEVIT FORREST;;SILBER JOHN;;STEPHEN ZACHARY;;CHIARELLI PETER,,https://lens.org/106-676-285-768-228,Patent Application,yes,2,1,2,2,2,A61K47/62;;A61K47/6923;;A61K47/6925;;A61K47/62;;A61K47/6923;;A61K47/6925;;A61P35/00;;A61K47/34;;C12N15/1137,A61K9/16;;A61K9/14,,0,0,,,,PENDING
34,EP,A1,EP 3762226 A1,075-815-991-858-903,2021-01-13,2021,EP 19715279 A,2019-03-06,US 201862639555 P;;US 2019/0020940 W,2018-03-07,POLYETHYLENE RECYCLABLE FILM WITH HIGH STRENGTH AND/OR BARRIER,,SEALED AIR CORP,DAYRIT RICHARD;;CHILDRESS BLAINE C;;ELLENBOGEN ERIC;;NAWABY ARGHAVAN V;;MOTCHAN TORI;;CHU EVA,,https://lens.org/075-815-991-858-903,Patent Application,yes,0,0,3,3,0,B32B27/08;;B32B27/304;;B32B27/306;;B32B27/32;;B32B27/327;;B32B27/34;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2250/24;;B32B2250/246;;B32B2250/40;;B32B2250/44;;B32B2307/31;;B32B2307/41;;B32B2307/548;;B32B2307/72;;B32B2307/748;;B32B2439/06;;B32B2439/40;;B32B2553/026;;B65D27/005;;B65D27/14;;B65D75/44;;B65D81/03;;B65D81/052;;B32B1/00;;B32B3/04;;B32B3/28;;B32B7/027;;B32B7/05;;B32B7/12;;Y02W30/80;;B32B7/05;;B32B7/027;;B32B3/04;;B32B27/08;;B32B27/304;;B32B27/306;;B32B27/32;;B32B27/34;;B32B2250/24;;B32B2307/31;;B32B2307/41;;B32B2307/548;;B65D27/005;;B65D27/14;;B65D65/40;;B65D81/03;;B65D81/052;;B32B3/28,B32B7/12;;B32B1/00;;B32B1/02;;B32B3/04;;B32B3/28;;B32B7/027;;B32B7/05;;B32B27/08;;B32B27/30;;B32B27/32;;B32B27/34;;B65D65/40;;B65D75/54,,0,0,,,,PENDING
35,US,A1,US 2014/0286872 A1,107-635-435-252-661,2014-09-25,2014,US 201414222443 A,2014-03-21,US 201414222443 A;;US 201361804033 P,2013-03-21,NANOPARTICLE FOR TARGETING BRAIN TUMORS AND DELIVERY OF O6-BENZYLGUANINE,"Nanoparticle having a crosslinked chitosan-polyethylene oxide oligomer copolymer coating to which O 6 -benzylguanine is covalently coupled, compositions that include the nanoparticle, and methods for using the nanoparticle to treat brain cancers.",UNIV WASHINGTON CT COMMERCIALI,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;KIEVIT FORREST;;SILBER JOHN R;;STEPHEN ZACHARY;;VEISEH OMID,UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (2014-03-27),https://lens.org/107-635-435-252-661,Patent Application,yes,1,7,2,2,0,A61K9/00;;A61K31/495;;A61K31/495;;A61K47/6923;;A61K47/6923;;A61K49/0093;;A61K49/0093;;G01N33/5091;;G01N33/5091,A61K9/14;;A61K31/52;;G01N33/50,424/9.3;;424/493;;514/55;;514/21.3;;424/9.6;;435/375;;435/29,2,1,088-262-951-197-965,10.1016/j.polymer.2009.12.003,"Teng et al. (Polymer 2010, 51, 639-646);;Liu et al. (J. Nanomater. 2010, 1-15)",ACTIVE
36,WO,A1,WO 2019/173469 A1,112-610-893-001-819,2019-09-12,2019,US 2019/0020940 W,2019-03-06,US 201862639555 P,2018-03-07,POLYETHYLENE RECYCLABLE FILM WITH HIGH STRENGTH AND/OR BARRIER,"Polyethylene recyclable composite article comprises multilayer film having first layer comprising polyolefin with a melting point ≤190°C, second layer comprising second polymer selected from amorphous polyamide, polyamide with melt point 191-205°C, polyvinylidene chloride w/melt point 191-205°C, and/or EVOH w/melt point 191-205°C, and tie layer between the first layer and the second layer. The multilayer film is bonded to itself or another component. The second polymer makes up 1 to 10 wt % of composite article weight, and composite article exhibits a composite melt index of from 0.5 to 4 grams/10 min at 190°C and 2.16 kg in a Composite Melt Index Test. A corresponding polyethylene recyclable multilayer film also exhibits 0.5 to 4 grams/10 min at 190°C and 2.16 kg in a Composite Melt Index Test.",SEALED AIR CORP,DAYRIT RICHARD;;CHILDRESS BLAINE C;;ELLENBOGEN ERIC;;NAWABY ARGHAVAN V;;MOTCHAN TORI;;CHU EVA,,https://lens.org/112-610-893-001-819,Patent Application,yes,25,1,3,3,0,B32B27/08;;B32B27/304;;B32B27/306;;B32B27/32;;B32B27/327;;B32B27/34;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2250/24;;B32B2250/246;;B32B2250/40;;B32B2250/44;;B32B2307/31;;B32B2307/41;;B32B2307/548;;B32B2307/72;;B32B2307/748;;B32B2439/06;;B32B2439/40;;B32B2553/026;;B65D27/005;;B65D27/14;;B65D75/44;;B65D81/03;;B65D81/052;;B32B1/00;;B32B3/04;;B32B3/28;;B32B7/027;;B32B7/05;;B32B7/12;;Y02W30/80;;B32B7/05;;B32B7/027;;B32B3/04;;B32B27/08;;B32B27/304;;B32B27/306;;B32B27/32;;B32B27/34;;B32B2250/24;;B32B2307/31;;B32B2307/41;;B32B2307/548;;B65D27/005;;B65D27/14;;B65D65/40;;B65D81/03;;B65D81/052;;B32B3/28,B32B7/12;;B32B1/00;;B32B1/02;;B32B3/04;;B32B3/28;;B32B7/027;;B32B7/05;;B32B27/08;;B32B27/30;;B32B27/32;;B32B27/34;;B65D65/40;;B65D75/54,,0,0,,,,PENDING
37,US,A1,US 2020/0406592 A1,043-340-851-891-907,2020-12-31,2020,US 201916978069 A,2019-03-06,US 201916978069 A;;US 201862639555 P;;US 2019/0020940 W,2018-03-07,POLYETHYLENE RECYCLABLE FILM WITH HIGH STRENGTH AND/OR BARRIER,"Polyethylene recyclable composite article comprises multilayer film having first layer comprising polyolefin with a melting point ≤190° C., second layer comprising second polymer selected from amorphous polyamide, polyamide with melt point 191-205° C., polyvinylidene chloride w/melt point 191-205° C., and/or EVOH w/melt point 191-205° C., and tie layer between the first layer and the second layer. The multilayer film is bonded to itself or another component. The second polymer makes up 1 to 10 wt % of composite article weight, and composite article exhibits a composite melt index of from 0.5 to 4 grams/10 min at 190° C. and 2.16 kg in a Composite Melt Index Test. A corresponding polyethylene recyclable multilayer film also exhibits 0.5 to 4 grams/10 min at 190° C. and 2.16 kg in a Composite Melt Index Test.",SEALED AIR CORP,DAYRIT RICHARD;;CHILDRESS BLAINE C;;ELLENBOGEN ERIC;;NAWABY ARGHAVAN V;;MOTCHAN TORI;;CHU EVA,,https://lens.org/043-340-851-891-907,Patent Application,yes,2,4,3,3,0,B32B27/08;;B32B27/304;;B32B27/306;;B32B27/32;;B32B27/327;;B32B27/34;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2250/24;;B32B2250/246;;B32B2250/40;;B32B2250/44;;B32B2307/31;;B32B2307/41;;B32B2307/548;;B32B2307/72;;B32B2307/748;;B32B2439/06;;B32B2439/40;;B32B2553/026;;B65D27/005;;B65D27/14;;B65D75/44;;B65D81/03;;B65D81/052;;B32B1/00;;B32B3/04;;B32B3/28;;B32B7/027;;B32B7/05;;B32B7/12;;Y02W30/80;;B32B7/05;;B32B7/027;;B32B3/04;;B32B27/08;;B32B27/304;;B32B27/306;;B32B27/32;;B32B27/34;;B32B2250/24;;B32B2307/31;;B32B2307/41;;B32B2307/548;;B65D27/005;;B65D27/14;;B65D65/40;;B65D81/03;;B65D81/052;;B32B3/28,B32B27/08;;B32B3/04;;B32B7/027;;B32B7/05;;B32B27/30;;B32B27/32;;B32B27/34;;B65D27/00;;B65D27/14;;B65D65/40;;B65D81/03,,0,0,,,,PENDING
38,ES,T3,ES 2360519 T3,195-815-927-934-984,2011-06-06,2011,ES 06739100 T,2006-03-20,US 67428005 P,2005-04-22,CONJUGADO DE CIANINA-CLOROTOXINA Y PROCEDIMIENTO PARA LA VISUALIZACION INTRAQUIRURGICA DEL CANCER.,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOUNDATION;;HUTCHINSON FRED CANCER RES,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,,https://lens.org/195-815-927-934-984,Granted Patent,no,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,0,0,,,,ACTIVE
39,EP,B1,EP 1877428 B1,035-772-818-576-533,2011-03-16,2011,EP 06739100 A,2006-03-20,US 2006/0010170 W;;US 67428005 P,2005-04-22,CYANINE- CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOUNDATION,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,"FRED HUTCHINSON CANCER RESEARCH CENTER, US (2011-09-05);;FRED HUTCHINSON CANCER CENTER; US (2022-09-16);;UNIVERSITY OF WASHINGTON, SEATTLE, US (2023-02-10);;UNIVERSITY OF WASHINGTON, US (2022-11-22);;UNIVERSITY OF WASHINGTON (2011-04-13);;FRED HUTCHINSON CANCER RESEARCH CENTER (2011-06-30);;FRED HUTCHINSON CANCER RESEARCH CENTER, 98109-, US (2011-09-05);;UNIVERSITY OF WASHINGTON; US (2022-09-13);;FRED HUTCHINSON CANCER CENTER, SEATTLE, US (2023-02-10);;FRED HUTCHINSON CANCER CENTER (2023-01-25);;FRED HUTCHINSON CANCER CENTER, US (2022-11-22)",https://lens.org/035-772-818-576-533,Granted Patent,yes,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,3,2,016-065-057-100-394;;028-723-617-551-773,10.1602/neurorx.2.1.44;;10.1007/bf03206641;;pmc539319;;15717056;;14871599;;10.1016/s0301-4622(03)00218-7,"Annual Report 2004 by the ""Joint Institute for Nanoscience"", Eds. D. B. Baer, C. T. Campbell, November 2005. ""Smart Superparamagnetic Imaging Probes for Brain Tumor Research"", J. Gunn.;;EGLETON R. D., DAVIS T. P.: ""Development of Neuropeptide Drugs that Cross the Blood-Brain Barrier"", J AM SOC EXP NEUROTHERAPEUTICS, vol. 2, January 2005 (2005-01-01), pages 44 - 53, XP025343798;;TATIKOLOV A S; COSTA S M B: ""Complexation of polymethine dyes with human serum albumin: a spectroscopic study"", BIOPHYSICAL CHEMISTRY, vol. 107, 1 January 2004 (2004-01-01), pages 33 - 49, XP002381135",ACTIVE
40,AT,T1,AT E502048 T1,117-546-881-264-951,2011-04-15,2011,AT 06739100 T,2006-03-20,US 67428005 P;;US 2006/0010170 W,2005-04-22,FLUORESZENTES CHLOROTOXINKONJUGAT UND VERFAHREN ZUR INTRAOPERATIVEN SICHTBARMACHUNG VON KREBS,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOUNDATION,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,,https://lens.org/117-546-881-264-951,Granted Patent,no,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,,,0,0,,,,ACTIVE
41,EP,A2,EP 1877428 A2,084-795-984-927-932,2008-01-16,2008,EP 06739100 A,2006-03-20,US 2006/0010170 W;;US 67428005 P,2005-04-22,CYANINE- CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOU,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,"FRED HUTCHINSON CANCER RESEARCH CENTER, US (2011-09-05);;FRED HUTCHINSON CANCER CENTER; US (2022-09-16);;UNIVERSITY OF WASHINGTON, SEATTLE, US (2023-02-10);;UNIVERSITY OF WASHINGTON, US (2022-11-22);;UNIVERSITY OF WASHINGTON (2011-04-13);;FRED HUTCHINSON CANCER RESEARCH CENTER (2011-06-30);;FRED HUTCHINSON CANCER RESEARCH CENTER, 98109-, US (2011-09-05);;UNIVERSITY OF WASHINGTON; US (2022-09-13);;FRED HUTCHINSON CANCER CENTER, SEATTLE, US (2023-02-10);;FRED HUTCHINSON CANCER CENTER (2023-01-25);;FRED HUTCHINSON CANCER CENTER, US (2022-11-22)",https://lens.org/084-795-984-927-932,Patent Application,yes,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,0,0,,,,ACTIVE
42,DE,D1,DE 602006020710 D1,164-273-191-553-733,2011-04-28,2011,DE 602006020710 T,2006-03-20,US 67428005 P;;US 2006/0010170 W,2005-04-22,FLUORESZENTES CHLOROTOXINKONJUGAT UND VERFAHREN ZUR INTRAOPERATIVEN SICHTBARMACHUNG VON KREBS,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",FRED HUTCHINSON CANCER RES FOUNDATION;;UNIV WASHINGTON,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,,https://lens.org/164-273-191-553-733,Granted Patent,no,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,0,0,,,,ACTIVE
43,US,A1,US 2007/0154965 A1,095-788-255-814-261,2007-07-05,2007,US 60000406 A,2006-11-14,US 60000406 A;;US 38598506 A;;US 67428005 P,2005-04-22,Chlorotoxin-labeled nanoparticle compositions and methods for targeting primary brain tumors,"Chlorotoxin-labeled nanoparticles that target primary brain tumors, compositions that include the nanoparticles, methods of imaging tissues using the nanoparticles, and methods for treating tissues using the nanoparticles.",ZHANG MIQIN;;OLSON JAMES M;;SZE RAYMOND;;ELLENBOGEN RICHARD G;;VEISEH OMID;;SUN CONROY;;GUNN JONATHAN W,ZHANG MIQIN;;OLSON JAMES M;;SZE RAYMOND;;ELLENBOGEN RICHARD G;;VEISEH OMID;;SUN CONROY;;GUNN JONATHAN W,FRED HUTCHINSON CANCER RESEARCH CENTER (2007-01-22);;WASHINGTON UNIVERSITY OF (2007-01-12),https://lens.org/095-788-255-814-261,Patent Application,yes,9,26,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,G01N33/574,435/7.23;;435/455;;977/902,0,0,,,,DISCONTINUED
44,US,A1,US 2023/0405145 A1,152-972-247-405-236,2023-12-21,2023,US 202118248139 A,2021-10-06,US 202118248139 A;;US 202063089403 P;;US 2021/0053753 W,2020-10-08,IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA,"A nanoparticle for targeted siRNA delivery comprising an iron oxide core and a chitosan-polyethylene glycol-polyethylenimine copolymer coating surrounding the core, chlorotoxin covalently coupled to the coating, and an siRNA reversibly associated to the coating by non-covalent interaction. Methods for making the nanoparticle and methods for using the nanoparticle to suppress the expression of O 6 -methylguanine-DNA methyltransferase (MGMT), treating brain cancer, and killing cancer stem cells.",UNIV WASHINGTON,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;WANG KUI;;KIEVIT FORREST M;;SILBER JOHN R;;STEPHEN ZACHARY;;CHIARELLI PETER A,UNIVERSITY OF WASHINGTON (2021-10-06),https://lens.org/152-972-247-405-236,Patent Application,yes,0,0,2,2,2,A61K47/62;;A61K47/6923;;A61K47/6925;;A61K47/62;;A61K47/6923;;A61K47/6925;;A61P35/00;;A61K47/34;;C12N15/1137,A61K47/69;;A61K47/34;;A61K47/62;;A61P35/00;;C12N15/113,,0,0,,,,PENDING
45,US,A1,US 2014/0241993 A1,066-498-645-687-862,2014-08-28,2014,US 201414273374 A,2014-05-08,US 201414273374 A;;US 89772107 A;;US 2006/0010170 W;;US 67428005 P,2005-04-22,FLUORESCENT CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;HUTCHINSON FRED CANCER RES,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES;;VEISHE MANDANA;;GABIKIAN PATRIK;;BAHRAMI S-BAHRAM,,https://lens.org/066-498-645-687-862,Patent Application,yes,4,9,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,A61B17/22;;C07K14/435;;A61K49/00;;G01N33/574,424/9.6;;530/300;;435/7.23;;514/1.2;;435/375;;606/110,2,2,013-199-652-970-567;;013-199-652-970-567,17335414;;10.1517/17425247.4.2.175;;17335414;;10.1517/17425247.4.2.175,"Mamelak et al (Expert Opin. Drug Deliv., 2007, Vol. 4, No. 2, pages 175-186.;;Mamelak et al (Expert Opin. Drug Deliv., 2007, Vol. 4, No. 2, pages 175-186.",DISCONTINUED
46,US,B2,US 8778310 B2,083-960-166-398-880,2014-07-15,2014,US 89772107 A,2007-08-31,US 89772107 A;;US 2006/0010170 W;;US 67428005 P,2005-04-22,Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES M;;VEISEH MANDANA;;GABIKIAN PATRIK;;BAHRAMI S-BAHRAM;;UNIV WASHINGTON;;HUTCHINSON FRED CANCER RES,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES M;;VEISEH MANDANA;;GABIKIAN PATRIK;;BAHRAMI S-BAHRAM,FRED HUTCHINSON CANCER RESEARCH CENTER (2008-01-22);;WASHINGTON UNIVERSITY OF (2008-04-14);;FRED HUTCHINSON CANCER CENTER (2022-03-30),https://lens.org/083-960-166-398-880,Granted Patent,yes,74,10,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,A61B5/00;;A61B8/00;;A61B10/00;;A61K38/16;;A61K49/00;;A61K51/08,424/9.6;;424/1.11;;424/1.65;;424/1.69,31,24,054-821-923-634-288;;009-498-083-230-272;;019-024-497-415-689;;011-306-165-996-389;;019-655-508-001-985;;003-464-398-363-332;;149-905-841-995-437;;014-264-683-268-986;;054-821-923-634-288;;005-826-885-809-029;;108-740-247-130-967;;059-164-173-990-121;;014-509-440-888-585;;016-065-057-100-394;;141-110-824-694-86X;;024-161-451-885-265;;022-153-512-298-505;;014-411-541-182-455;;028-723-617-551-773;;043-888-457-701-427;;070-631-400-706-871;;047-365-285-601-835;;021-837-168-406-052;;134-006-521-216-920,10.1021/nl0502569;;15943433;;14623938;;10.1177/002215540305101214;;10.1016/s0927-7757(00)00633-6;;15078992;;10.1158/1535-7163.481.3.4;;10.1074/jbc.m205662200;;12454020;;10.1021/ja049195r;;15186157;;9809993;;10.1021/ja026501x;;12105897;;10.1021/nl0502569;;15943433;;10.1038/nm0103-123;;12514725;;11922461;;10.1016/s0142-9612(01)00267-8;;15601762;;10.1073/pnas.0408191101;;pmc539314;;21210710;;pmc3086956;;10.1021/jm101018r;;10.1602/neurorx.2.1.44;;10.1007/bf03206641;;pmc539319;;15717056;;15809479;;10.1016/j.jchromb.2003.11.029;;15025999;;20209054;;pmc2832013;;10.1371/annotation/fe02e23b-5168-4586-ba49-d0e0286f4ad3;;10.1371/journal.pone.0009536;;10.1093/jnci/88.18.1308;;8797771;;14871599;;10.1016/s0301-4622(03)00218-7;;9891977;;10.1016/s0014-5793(98)01589-0;;19638572;;10.1158/0008-5472.can-09-1157;;pmc2742601;;17638899;;10.1158/0008-5472.can-06-3948;;8589602;;10.1007/bf00211777;;10.1002/(sici)1098-2299(199707/08)41:3/4<142::aid-ddr5>3.0.co;2-l,"Veiseh et al (Nano Letters, Apr. 30, 2005, vol. 5, No. 6, pp. 1003-1008).;;Berlier, J.E., et al., ""Quantitative Comparison of Long-Wavelength Alexa Fluor Dyes to Cy Dyes: Fluorescence of the Dyes and Their Bioconjugates,"" The Journal of Histochemistry & Cytochemistry 51(12):1699-1712, 2003.;;Butterworth, M.D., et al., ""Preparation of Ultrafine Silica- and PEG-Coated Magnetite Particles,"" Colloids and Surfaces A: Physicochemistry Engineering Aspects 179:93 102, 2001.;;Citrin, D., et al., ""In Vivo Tumor Imaging in Mice With Near-Infrared Labeled Endostatin,"" Molecular Cancer Therapeutics 3(4):481-488, 2004.;;Deshane, J., et al., ""Chlorotoxin Inhibits Glioma Cell Invasion Via Matrix Metalloproteinase-2,"" The Journal of Biological Chemistry 278(6):4135-4144, Feb. 7, 2003.;;Kohler, N., et al., ""A Bifunctional Poly(Ethylene Glycol) Silane Immobilized on Metallic Oxide Based Nanoparticles for Conjugation With Cell Targeting Agents,"" Journal of the American Chemical Society 126(23):7206 7211, 2004.;;Soroceanu, L., et al., ""Use of Chlorotoxin for Targeting of Primary Brain Tumors,"" Cancer Research 58:4871-4879, Nov. 1, 1998.;;Sun, S., and H. Zeng, ""Size Controlled Synthesis of Magnetite Nanoparticles,"" Journal of the American Chemical Society 124(28):8204 8205, 2002.;;Veiseh, O., et al., ""Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas,"" Nano Letters 5(6):1003-1008, 2005.;;Weissleder, R., and V. Ntziachristos, ""Shedding Light Onto Live Molecular Targets,"" Nature Medicine 9 (1):123-128, Jan. 2003.;;Zhang, Y., et al., ""Surface Modification of Superparamagnetic Magnetite Nanoparticles and Their Intracellular Uptake,"" Biomaterials 23:1553 1561, 2002.;;Gunn, J., et al., ""Smart Superparamagnetic Imaging Probes for Brain Tumor Research,"" in D.B. Baer and C.T. Campbell (eds.), Joint Institute for Nanoscience Annual Report, 2004, Nov. 2005, pp. 3.65-3.66.;;Jiang, T., et al., ""Tumor Imaging by Means of Proteolytic Activation of Cell-Penetrating Peptides,"" Proceedings of the National Academy of Sciences USA (PNAS) 101(51):17867-17872, Dec. 2004.;;Invitation Pursuant to Article 94(3) and Rule 71(1) EPC, mailed Mar. 1, 2010, in corresponding European Application No. 06 739 100.3, filed Mar. 20, 2006, 3 pages.;;Akcan, et al. Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J Med Chem. Feb. 10, 2011;54(3):782-7. doi: 10.1021/jm101018r. Epub Jan. 6, 2011;;Egleton, R.D. and Davis, T.P., Development of Neuropeptide Drugs that Cross the Blood-Brain Barrier, J. Am. Soc. Exp. NeuroTherapeutics 2:44-53 (2005).;;European search report and search opinion dated Oct. 15, 2013 for EP Application No. 11780950.9.;;Hockaday, D.C. et al., Imaging Glioma Extent with 131I-TM-601, J. Nuc. Med. 46(4): 580-586 (2005).;;Huys, et al. Structure-function study of a chlorotoxin-chimer and its activity on Kv1.3 channels. J Chromatogr B Analyt Technol Biomed Life Sci. Apr. 15, 2004; 803(1):67-73.;;International search report and written opinion dated Oct. 6, 2010 for PCT/US2006/010170.;;International search report and written opinion dated Nov. 18, 2011 for PCT/US2011/023797.;;Lee, M. J., et al., Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-conjugated Iron oxide Nanoparticles: A Novel Non-Radioactive Method, PLoS One 5(3):e9536 1-8 (2010).;;Milross, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst. Sep. 18, 1996; 88(18):1308-14.;;Tatikolov, A.S. And Costa, S.M.B., Complexation of polymethine dyes with human serum albumin: a spectroscopic study, Biophys. Chem. 107:33-49 (2004).;;Tytgat, et al. Purification and partial characterization of a 'short' insectotoxin-like peptide from the venom of the scorpion Parabuthus schlechteri. FEBS Lett. Dec. 28, 1998; 441(3):387-91.;;Veiseh, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res. Aug. 1, 2009; 69(15):6200-7. doi: 10.1158/0008-5472.CAN-09-1157. Epub Jul. 28, 2009.;;Veiseh, et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. Jul. 15, 2007; 67(14):6882-8.;;Wishart, et al. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J.Biomol NMR. Sep. 1995; 6(2):135-40.;;International search report and written opinion dated Apr. 8, 2014 for PCT/US2013/074215.;;International search report and written opinion dated Apr. 22, 2014 for PCT/US2013/074218.;;Shiue. Identification of candidate genes for drug discovery by differential display Drug Development Research. New York. 1997; 41:142-159.",ACTIVE
47,US,A1,US 2008/0279780 A1,100-286-189-890-002,2008-11-13,2008,US 89772107 A,2007-08-31,US 89772107 A;;US 2006/0010170 W;;US 67428005 P,2005-04-22,Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;HUTCHINSON FRED CANCER RES,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES M;;VEISEH MANDANA;;GABIKIAN PATRICK;;BAHRAMI S-BAHRAM,FRED HUTCHINSON CANCER RESEARCH CENTER (2008-01-22);;WASHINGTON UNIVERSITY OF (2008-04-14);;FRED HUTCHINSON CANCER CENTER (2022-03-30),https://lens.org/100-286-189-890-002,Patent Application,yes,40,17,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,A61K49/00,424/9.6,0,0,,,,ACTIVE
48,US,A1,US 2022/0152091 A1,086-763-757-257-728,2022-05-19,2022,US 202117379401 A,2021-07-19,US 202117379401 A;;US 201815766314 A;;US 2016/0055809 W;;US 201562237915 P,2015-10-06,OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY,"Methods and compositions for treating traumatic brain injury. The methods and compositions utilize a multi-functional oxygen reactive polymer (ORP) that includes repeating units that include a reactive oxygen species (ROS) scavenging group and a polyalkylene oxide group. For theranostic applications, the oxygen reactive polymer further includes a diagnostic group.",UNIV WASHINGTON,STAYTON PATRICK S;;YPMA MENKO P;;CHIARELLI PETER A;;PARK JOSHUA SANG HUN;;ELLENBOGEN RICHARD G;;XU JULIA MENGYUN;;MOURAD PIERRE D;;LEE DONGHOON;;CONVERTINE ANTHONY;;KIEVIT FORREST M,,https://lens.org/086-763-757-257-728,Patent Application,yes,0,0,4,4,0,A61K47/30;;A61K9/14;;A61P25/28;;A61K31/765;;A61K31/795;;A61K47/30;;A61K9/14;;A61P25/28;;A61K9/0019;;A61K9/51;;A61K31/765;;A61K31/795,A61K31/765;;A61K9/00;;A61K9/14;;A61K9/51;;A61K31/795;;A61K47/30;;A61P25/28,,0,0,,,,PENDING
49,WO,A1,WO 2017/062657 A1,177-464-848-737-347,2017-04-13,2017,US 2016/0055809 W,2016-10-06,US 201562237915 P,2015-10-06,OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY,"Methods and compositions for treating traumatic brain injury. The methods and compositions utilize a multi-functional oxygen reactive polymer (ORP) that includes repeating units that include a reactive oxygen species (ROS) scavenging group and a polyalkylene oxide group. For theranostic applications, the oxygen reactive polymer further includes a diagnostic group.",UNIV OF WAHSINGTON,XU JULIA MENGYUN;;YPMA MENKO R;;CHIARELLI PETER A;;PARK JOSHUA SANG HUN;;ELLENBOGEN RICHARD G;;STAYTON PATRICK S;;MOURAD PIERRE D;;LEE DONGHOON;;CONVERTINE ANTHONY;;KIEVIT FORREST M,,https://lens.org/177-464-848-737-347,Patent Application,yes,4,3,4,4,0,A61K47/30;;A61K9/14;;A61P25/28;;A61K31/765;;A61K31/795;;A61K47/30;;A61K9/14;;A61P25/28;;A61K9/0019;;A61K9/51;;A61K31/765;;A61K31/795,A61P25/00;;A61K47/30;;C07K14/805,,1,1,033-350-450-718-480,8433137;;10.3171/jns.1993.78.3.0375,"MUIZELAAR ET AL.: ""Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycolconjugated superoxide dismutase: a Phase II trial."", JOURNAL OF NEUROSURGERY, vol. 78, no. 3, 1993, pages 375 - 382, Retrieved from the Internet <URL:http://thejns.org/doi/abs/10,3171/jnepsilon.1993.78.3.0375?url_ver=Z39.88-2003&rfr_id-ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&> [retrieved on 20012017]",PENDING
50,US,B2,US 11065272 B2,027-745-356-809-270,2021-07-20,2021,US 201615766314 A,2016-10-06,US 201615766314 A;;US 201562237915 P;;US 2016/0055809 W,2015-10-06,Oxygen reactive polymers for treatment of traumatic brain injury,"Methods and compositions for treating traumatic brain injury. The methods and compositions utilize a multi-functional oxygen reactive polymer (ORP) that includes repeating units that include a reactive oxygen species (ROS) scavenging group and a polyalkylene oxide group. For theranostic applications, the oxygen reactive polymer further includes a diagnostic group.",UNIV WASHINGTON,STAYTON PATRICK S;;YPMA MENKO P;;CHIARELLI PETER A;;PARK JOSHUA SANG HUN;;ELLENBOGEN RICHARD G;;XU JULIA MENGYUN;;MOURAD PIERRE D;;LEE DONGHOON;;CONVERTINE ANTHONY;;KIEVIT FORREST M,UNIVERSITY OF WASHINGTON (2018-11-01),https://lens.org/027-745-356-809-270,Granted Patent,yes,7,0,4,4,0,A61K47/30;;A61K9/14;;A61P25/28;;A61K31/765;;A61K31/795;;A61K47/30;;A61K9/14;;A61P25/28;;A61K9/0019;;A61K9/51;;A61K31/765;;A61K31/795,A61K31/765;;A61K9/00;;A61K9/14;;A61K9/51;;A61K31/795;;A61K47/30;;A61P25/28,,52,50,041-572-277-793-877;;049-161-556-854-382;;018-341-951-827-038;;081-297-869-273-733;;060-375-693-808-739;;008-976-672-288-488;;078-095-158-303-939;;048-418-018-879-843;;026-501-702-320-498;;021-480-171-483-80X;;026-080-553-072-386;;054-716-316-649-635;;117-773-330-241-016;;054-941-682-226-481;;040-118-190-236-350;;018-026-116-357-247;;038-678-253-697-634;;031-472-968-068-032;;101-452-782-767-424;;026-441-096-336-331;;007-417-001-564-86X;;010-571-719-659-992;;098-374-665-602-164;;033-834-296-851-902;;064-400-365-392-508;;082-405-046-309-258;;036-588-706-788-933;;056-364-022-781-231;;009-017-663-250-720;;039-474-172-356-004;;101-264-658-320-256;;018-054-995-043-559;;035-711-439-338-747;;074-572-551-205-482;;038-415-706-844-39X;;023-917-558-988-29X;;127-461-571-161-164;;027-024-518-203-926;;059-820-202-402-580;;045-585-236-680-639;;096-420-725-243-899;;057-370-947-247-249;;088-366-337-225-926;;009-425-294-524-37X;;058-987-485-267-742;;036-302-547-403-517;;128-121-226-620-02X;;022-532-246-722-616;;106-082-161-650-211;;033-350-450-718-480,10.1016/s0196-0644(05)82744-1;;8503521;;17018310;;10.1016/j.crad.2006.06.011;;10.1089/ars.2009.2668;;19624272;;10739643;;10.1006/exnr.1999.7338;;25918580;;pmc4397034;;10.1155/2015/370312;;10.1021/nn102845t;;22017172;;8751635;;10.3171/jns.1996.85.3.0476;;10.1038/mt.2015.22;;25669432;;pmc4427876;;10.1021/nn302615f;;22866916;;pmc3458163;;26079716;;10.3109/1061186x.2015.1034280;;10.1021/cr9001403;;19764725;;pmc4061598;;24994996;;10.3389/fneur.2014.00100;;22242774;;10.1021/ar200242z;;pmc3516364;;10.3410/f.7980956.8351056;;10.1016/s1474-4422(10)70300-8;;pmc3628679;;21169065;;10.1371/journal.pone.0061819;;pmc3634829;;23637912;;10.1089/ars.2012.4981;;23547621;;26708021;;10.1016/j.jconrel.2015.12.029;;10.1186/s12989-015-0108-2;;26525058;;pmc4630844;;10.1016/j.nurt.2009.10.021;;20129497;;pmc2818465;;10.1021/nn403743b;;24266731;;pmc4252540;;10.1523/jneurosci.3020-14.2014;;25471560;;20393189;;10.1126/scitranslmed.3000330;;pmc4636982;;25947369;;10.1007/s11064-015-1581-6;;pmc4449023;;26024446;;10.1371/journal.pone.0127971;;pmc3397249;;10.1002/adma.201102313;;21842473;;pmc4470501;;26097514;;10.1039/c4py01250j;;16983222;;10.1097/00001199-200609000-00001;;pmc4146500;;10.1002/adhm.201200423;;25136729;;10.1089/neu.2000.17.871;;11063054;;10.1227/neu.0b013e31820c02d9;;21273921;;10.2165/11634020-000000000-00000;;22668124;;10.1155/2013/379206;;pmc3654699;;23710445;;10.1071/ch12295;;10.7150/thno.8698;;pmc3982135;;24723986;;16257340;;10.1016/s0140-6736(05)67626-x;;19124559;;10.1096/fj.08-116947;;18509606;;pmc2670226;;10.1007/s12010-008-8232-1;;10.2174/0929867321666131217153310;;24350853;;9271001;;10.1007/bf02815156;;pmc3930079;;24317693;;10.1038/nature12808;;25221630;;pmc4159953;;10.1039/c3py01404e;;24201802;;10.1038/cddis.2013.362;;pmc3847304;;19413362;;10.1021/bm900325t;;pmc4667711;;26274493;;10.3109/02699052.2015.1065344;;10.1021/jf402242e;;23706102;;pmc3854945;;24241345;;10.1038/aps.2013.160;;10.1039/c4py01156b;;20691229;;10.1016/j.addr.2010.07.009;;pmc2988080;;10.1002/adfm.201504416;;8433137;;10.3171/jns.1993.78.3.0375,"Muizelaar, Cerebral ischemia-reperfusion injury after severe head injury and its possible treatment with polyethyleneglycol-superoxide dismutase, 1993, Annals of Emergency Medicine, vol. 22, Issue 6, pp. 1014-1021, Abstract only (3 pages). (Year: 1993).;;McKenna, Polyethylene glycol solution as an oral contrast agent for MRI of the small bowel in a patient population, 2006, Clinical Radiology, vol. 61, Issue 11, pp. 966-970, Abstract only (3 pages). (Year: 2006).;;Adibhatla, R.M., and J.F. Hatcher, “Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities,” Antioxidants & Redox Signaling 12(1):125-169, Jan. 2010.;;Albensi, B.C., et al., “Cyclosporin Ameliorates Traumatic Brain-Injury-Induced Alterations of Hippocampal Synaptic Plasticity,” Experimental Neurology 162(12):385-389, Dec. 2000.;;Angeloni, C., et al., “Traumatic Brain Injury and NADPH Oxidase: A Deep Relationship,” Oxidative Medicine and Cellular Longevity 2015:370312, 2015, pp. 1-10.;;Astete, C.E., et al., “Antioxidant Poly(lactic-co-glycolic) Acid Nanoparticles Made With R-Tocopherol Ascorbic Acid Surfactant,” ACS Nano 5(12):9313-9325, Dec. 2011.;;Baldwin, S.A., et al., “Blood-Brain Banier Breach Following Cortical Contusion in the Rat,” Journal of Neurosurgery 85(3):476-481, Sep. 1996.;;Berguig, G.Y., et al., “Intracellular Delivery System for Antibody-Peptide Drug Conjugates,” American Society of Gene & Cell Therapy 23(5):907-917, May 2015.;;Bitner, B.R., et al., “Antioxidant Carbon Particles Improve Cerebrovascular Dysfunction Following Traumatic Brain Injury,” ACS Nano 6(9):8007-8014, Sep. 2012.;;Boyd, B.J., et al., “Traumatic Brain Injury Opens Blood-Brain Barrier to Stealth Liposomes via an Enhanced Permeability and Retention (EPR)-Like Effect,” Journal of Drug Targeting 23(9):847-853, 2015.;;Boyer, C., et al., “Bioapplications of RAFT Polymerization,” Chemical Reviews 109(11):5402-5436, Nov. 2009.;;Chen, Y., et al., “A Modified Controlled Cortical Impact Technique to Model Mild Traumatic Brain Injury Mechanics in Mice,” Frontiers in Neurology 5:100, Jun. 2014, pp. 1-14.;;Chu, D.S.H., et al., “Application of Living Free Radical Polymerization for Nucleic Acid Delivery,” Accounts of Chemical Research 45(7):1089-1099, Jul. 2012.;;Clifton, G.L., et al., “Very Early Hypothermia Induction in Patients With Severe Brain Injury (the National Acute Brain Injury Study: Hypothermia II): A Randomised Trial,” The Lancet Neurology 10(2):131-139, Feb. 2011.;;Clond, M.A., et al., “Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice,” PLOS ONE 8(4):e61819, Apr. 2013, 10 pages.;;Cornelius, C., et al., “Traumatic Brain Injury: Oxidative Stress and Neuroprotection,” Antioxidants & Redox Signaling 19(8):836-853, Sep. 2013.;;Cruz, L.J., et al., “Effect of PLGA NP Size on Efficiency to Target Traumatic Brain Injury,” Journal of Controlled Release 223:31-41, Feb. 2016.;;Driessen, M.D., et al., “Proteomic Analysis of Protein Carbonylation: A Useful Tool to Unravel Nanoparticle Toxicity Mechanisms,” Particle and Fibre Toxicology 12:36, Dec. 2015, pp. 1-18.;;Frieden, T.R., et al., “Report to Congress: Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation,” submitted by Centers for Disease Control and Prevention, National Center for Injury Prevention and control, Atlanta, GA, 2015, 72 pages.;;Hall, E.D., et al., “Antioxidant Therapies for Traumatic Brain Injury,” Neurotherapeutics 7(1):51-61, Jan. 2010.;;Heckman, K.L., et al., “Custom Cerium Oxide Nanoparticles Protect Against a Free Radical Mediated Autoimmune Degenerative Disease in the Brain,” ACS Nano 7(12):10582-10596, Dec. 2013.;;Iliff, J.J., et al., “Impairment of Glymphatic Pathway Function Promotes Tau Pathology After Traumatic Brain Injury,” Journal of Neuroscience 34(49):16180-16193, Dec. 2014.;;Janowitz, T., and D.K. Menon, “Exploring New Routes for Neuroprotective Drug Development in Traumatic Brain Injury,” Science Translational Medicine 2(27):1-10, Apr. 2010.;;Jessen, N.A., et al., “The Glymphatic System: A Beginner's Guide,” Neurochemical Research 40(12):2583-2599, Dec. 2015.;;Kabu, S., et al., “Blast-Associated Shock Waves Result in Increased Brain Vascular Leakage and Elevated ROS Levels in a Rat Model of Traumatic Brain Injury,” PLOS ONE 10(5):e0127971, May 2015, 19 pages.;;Kievit, F.M., and M. Zhang, “Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers,” Advanced Healthcare Materials 23(36):H217-H247, 2011.;;Lane, D.D., et al., “Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents,” Polymeric Chemistry 6(8):1286-1299, Feb. 2015. (Author Manuscript provided, PMCID: PMC4470501, available in PMC Feb. 28, 2016, 31 pages.).;;Langlois, J.A., et al., “The Epidemiology and Impact of Traumatic Brain Injury,” Journal of Head Trauma Rehabilitation 21(5):375-378, 2006.;;Lee, S.H., et al., “Current Progress in Reactive Oxygen Species (ROS)-Responsive Materials for Biomedical Applications,” Adv Healthc Mat 2(6):908-915, 2013. (Author Manuscript provided, PMCID: PMC4146500, available in PMC Aug. 27, 2014, 15 pages.).;;Lewén, A., et al., “Free Radical Pathways in CNS Injury,” Journal of Neurotrauma 17(10):871-890, Oct. 2000.;;Marushima, A., et al., “Newly Synthesized Radical-Containing Nanoparticles Enhance Neuroprotection After Cerebral Ischemia-Reperfusion Injury,” Neurosurgery 68(5):1418-1426, May 2011.;;McConeghy, K.W., et al., “A Review of Neuroprotection Pharmacology and Therapies in Patients With Acute Traumatic Brain Injury,” CNS Drugs 26(7):613-636, Jul. 2012.;;Miyamoto, K., et al., “Therapeutic Time Window for Edaravone Treatment of Traumatic Brain Injury in Mice,” BioMed Research International 2013:379206, 2013, pp. 1-13.;;Moad, G., et al., “Living Radical Polymerization by the RAFT Process—A Third Update,” Australian Journal of Chemistry 65(8):985-1076, Sep. 2012.;;Muthu, M.S., et al., “Nanotheranostics—Application and Further Development of Nanomedicine Strategies for Advanced Theranostics,” Theranostics 4(6):660-677, Mar. 2014.;;Patel, H.C., et al., “Trends in Head Injury Outcome From 1989 to 2003 and the Effect of Neurosurgical Care: An Observational Study,” The Lancet 366(9496):1538-1544, Oct.-Nov. 2005.;;Reddy, M.K., and V. Labhasetwar, “Nanoparticle-Mediated Delivery of Superoxide Dismutase to the Brain: An Effective Strategy to Reduce Ischemia-Reperfusion Injury,” FASEB Journal 23(5):1384-1395, May 2009.;;Reddy, M.K., et al., “Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress,” Applied Biochemistry and Biotechnology 151:565-577, Dec. 2008.;;Rodríguez-Rodríguez, A., et al., “Oxidative Stress in Traumatic Brain Injury,” Current Medicinal Chemistry 21(10):1201-1211, Apr. 2014.;;Roof, R.L., et al., “Progesterone Protects Against Lipid Peroxidation Following Traumatic Brain Injury in Rats,” Molecular and Chemical Neuropathology 31(1):1-11, May 1997.;;Roth, T.L., et al., “Transcranial Amelioration of Inflammation and Cell Death After Brain Injury,” Nature 505(7482):223-228, Jan. 2014.;;Roy, D., et al., “Synthesis and Characterization of Transferrin-Targeted Chemotherapeutic Delivery Systems Prepared via RAFT Copolymerization of High Molecular Weight PEG Macromonomers,” Polymeric Chemistry 5(5):1791-1799, Mar. 2014. (Author Manuscript provided, PMCID: PMC4159953, available in PMC Mar. 7, 2015, 21 pages.).;;Singhal, A., et al., “Nanoparticle-Mediated Catalase Delivery Protects Human Neurons From Oxidative Stress,” Cell Death and Disease 4:e903, 2013, 9 pages.;;Spizzirri, U.G., et al., “Synthesis of Antioxidant Polymers by Grafting of Gallic Acid and Catechin on Gelatin,” Biomacromolecules 10(7):1923-1930, Jul. 2009.;;Stein, D.G., “Embracing Failure: What the Phase III Progesterone Studies Can Teach About TBI Clinical Trials,” Brain Injury 29(11):1259-1272, 2015.;;Wan, A., et al., “Antioxidant Activity of High Molecular Weight Chitosan and N,O-Quatemized Chitosans,” Journal of Agricultural and Food Chemistry 61(28):6921-6928, Jul. 2013.;;Wei, J., and G.-M. Xiao, “The Neuroprotective Effects of Progesterone on Traumatic Brain Injury: Current Status and Future Prospects,” Acta Pharmacologica Sinica 34(12):1485-1490, Dec. 2013.;;Xiao, C., et al., “Synthesis of Thermal and Oxidation Dual Responsive Polymers for Reactive Oxygen Species (ROS)-Triggered Drug Release,” Polymer Chemistry 6(5):738-747, Feb. 2015.;;Xie, J., et al., “Nanoparticle-Based Theranostic Agents,” Advanced Drug Delivery Reviews 62(11):1064-1079, Aug. 2010.;;Xu, J., et al., “Theranostic Oxygen Reactive Polymers for Treatment of Traumatic Brain Injury,” Advanced Functional Materials 26(23):4124-4133, 2016.;;International Search Report and Written Opinion dated Mar. 10, 2017, issued in corresponding International Application No. PCT/US2016/055809, filed Oct. 6, 2016, 11 pages.;;Muizelaar, J.P., et al., “Improving the Outcome of Severe Head Injury With the Oxygen Radical Scavenger Polyethylene Glycol-Conjugated Superoxide Dismutase: A Phase II Trial,” Journal of Neurosurgery 78(3):375-382, Mar. 1993.",ACTIVE
51,US,A1,US 2018/0289736 A1,053-701-856-956-806,2018-10-11,2018,US 201615766314 A,2016-10-06,US 201615766314 A;;US 201562237915 P;;US 2016/0055809 W,2015-10-06,OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY,"Methods and compositions for treating traumatic brain injury. The methods and compositions utilize a multi-functional oxygen reactive polymer (ORP) that includes repeating units that include a reactive oxygen species (ROS) scavenging group and a polyalkylene oxide group. For theranostic applications, the oxygen reactive polymer further includes a diagnostic group.",UNIV WASHINGTON,STAYTON PATRICK S;;YPMA MENKO R;;CHIARELLI PETER A;;PARK JOSHUA SANG HUN;;ELLENBOGEN RICHARD G;;XU JULIA MENGYUN;;MOURAD PIERRE D;;LEE DONGHOON;;CONVERTINE ANTHONY;;KIEVIT FORREST M,UNIVERSITY OF WASHINGTON (2018-11-01),https://lens.org/053-701-856-956-806,Patent Application,yes,0,0,4,4,0,A61K47/30;;A61K9/14;;A61P25/28;;A61K31/765;;A61K31/795;;A61K47/30;;A61K9/14;;A61P25/28;;A61K9/0019;;A61K9/51;;A61K31/765;;A61K31/795,A61K31/765;;A61K9/00;;A61K9/51;;A61K31/795;;A61P25/28,,0,0,,,,ACTIVE
52,US,A1,US 2016/0213299 A1,174-503-510-833-163,2016-07-28,2016,US 201514929338 A,2015-10-31,US 201514929338 A;;US 201562108047 P,2015-01-26,One or More Machines/Articles/Compositions/Processes Related to Traumatic Brain Injuries,A method substantially as shown and described in the detailed description and/or drawings and/or elsewhere herein. A device substantially as shown and described in the detailed description and/or drawings and/or elsewhere herein.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID LOZOFF;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD GLEN;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H;;LORD RICHARD T;;LORD ROBERT W,,https://lens.org/174-503-510-833-163,Patent Application,yes,6,3,1,3,0,A61B5/4064;;A61B5/4064;;A61B5/1112;;A61B5/1112;;A61B5/6803;;A61B5/6803;;A61B2503/10;;A61B2503/10;;A61B2562/0219;;A61B2562/0219,A61B5/00;;A61B5/11,,0,0,,,,DISCONTINUED
53,US,A1,US 2016/0213300 A1,022-679-989-788-735,2016-07-28,2016,US 201615006577 A,2016-01-26,US 201615006577 A;;US 201514929338 A;;US 201562108047 P,2015-01-26,One or More Machines/Articles/Compositions/Processes Related to Traumatic Brain Injuries,"Computationally implemented methods and systems include electronically collecting player acceleration data associated with a head of a sports player, electronically monitoring game time player status data of the sports player, and electronically obtaining player brain injury status data associated with brain injury status of the sports player based at least in part upon the player acceleration data and the game time player status data of the sports player. In addition to the foregoing, other aspects are described in the claims, drawings, and text.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID LOZOFF;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD GLEN;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H;;LORD RICHARD T;;LORD ROBERT W,,https://lens.org/022-679-989-788-735,Patent Application,yes,10,7,1,3,0,A61B5/4064;;A61B5/4064;;A61B5/6803;;A61B5/6803;;A61B2503/10;;A61B2503/10;;A61B2562/0219;;A61B2562/0219,A61B5/00;;A61B5/11,,0,0,,,,DISCONTINUED
54,US,A1,US 2016/0220167 A1,145-247-111-681-391,2016-08-04,2016,US 201615011531 A,2016-01-30,US 201615011531 A;;US 201514929338 A;;US 201615006577 A;;US 201562108047 P,2015-01-26,One or More Machines/Articles/Compositions/Processes Related to Traumatic Brain Injuries,"Computationally implemented methods and systems include electronically collecting player acceleration data associated with a head of a sports player, electronically monitoring game time player status data of the sports player, and electronically obtaining player brain injury status data associated with brain injury status of the sports player based at least in part upon the player acceleration data and the game time player status data of the sports player. In addition to the foregoing, other aspects are described in the claims, drawings, and text.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID LOZOFF;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD GLEN;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H;;LORD RICHARD T;;LORD ROBERT W,,https://lens.org/145-247-111-681-391,Patent Application,yes,0,9,1,3,0,A61B5/4064;;A61B5/4064;;A61B5/1112;;A61B5/1112;;A61B5/1121;;A61B5/1121;;A61B5/1128;;A61B5/1128;;A61B5/6803;;A61B5/6803;;A61B5/7282;;A61B5/7282;;A61B2503/10;;A61B2503/10;;A63B2220/30;;A63B2220/40,A61B5/00;;A61B5/103,,0,0,,,,DISCONTINUED
55,US,B2,US 9730482 B2,174-484-180-888-821,2017-08-15,2017,US 201414549237 A,2014-11-20,US 201414549237 A,2014-11-20,System and method for airbag deployment and inflation,"A helmet with an airbag assembly coupled to the shell of the helmet. The airbag assembly includes an airbag and an inflation device. The inflation device is configured to at least partially inflate the airbag upon deployment of the airbag assembly. The helmet also includes a processing circuit disposed at least partially within the shell. The processing circuit is configured to receive helmet data regarding a second helmet, transmit deployment data regarding inflation of the airbag assembly, and control operation of the inflation device to inflate the airbag based on the helmet data.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2010-10-13),https://lens.org/174-484-180-888-821,Granted Patent,yes,64,12,3,3,0,A42B3/0486;;A42B3/0486;;A42B3/00;;A42B3/0406;;A42B3/046;;A42B3/122;;G08C17/02,A42B3/04;;A42B3/00;;G08C17/02,,0,0,,,,INACTIVE
56,US,A1,US 2016/0143383 A1,162-230-308-071-955,2016-05-26,2016,US 201414549237 A,2014-11-20,US 201414549237 A,2014-11-20,SYSTEM AND METHOD FOR AIRBAG DEPLOYMENT AND INFLATION,"A helmet with an airbag assembly coupled to the shell of the helmet. The airbag assembly includes an airbag and an inflation device. The inflation device is configured to at least partially inflate the airbag upon deployment of the airbag assembly. The helmet also includes a processing circuit disposed at least partially within the shell. The processing circuit is configured to receive helmet data regarding a second helmet, transmit deployment data regarding inflation of the airbag assembly, and control operation of the inflation device to inflate the airbag based on the helmet data.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2010-10-13),https://lens.org/162-230-308-071-955,Patent Application,yes,2,11,3,3,0,A42B3/0486;;A42B3/0486;;A42B3/00;;A42B3/0406;;A42B3/046;;A42B3/122;;G08C17/02,A42B3/04;;A42B3/12;;G05B15/02;;G05D7/06,,0,0,,,,INACTIVE
57,US,A1,US 2017/0325533 A1,028-748-520-679-325,2017-11-16,2017,US 201715669687 A,2017-08-04,US 201715669687 A;;US 201514663315 A,2015-03-19,HELMET AIRBAG SYSTEM,An airbag inflation system includes a processing circuit configured to receive object data including positional data regarding an object and at least one of a relative velocity and a relative acceleration of the object relative to a first helmet and control operation of an inflation device to inflate an airbag based on the object data.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/028-748-520-679-325,Patent Application,yes,7,2,3,3,0,A42B3/0486;;A42B3/0486;;A41D13/00;;A41D13/018;;A41D13/0512;;A42B3/00;;A42B3/12;;A42B3/122,A42B3/04;;A41D13/00;;A41D13/018;;A41D13/05;;A42B3/00;;A42B3/12,,0,0,,,,DISCONTINUED
58,US,A1,US 2016/0270472 A1,155-387-239-644-802,2016-09-22,2016,US 201514663315 A,2015-03-19,US 201514663315 A,2015-03-19,HELMET AIRBAG SYSTEM,An airbag inflation system includes a processing circuit configured to receive object data including positional data regarding an object and at least one of a relative velocity and a relative acceleration of the object relative to a first helmet and control operation of an inflation device to inflate an airbag based on the object data.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-06-02),https://lens.org/155-387-239-644-802,Patent Application,yes,9,17,3,3,0,A42B3/0486;;A42B3/0486;;A41D13/00;;A41D13/018;;A41D13/0512;;A42B3/00;;A42B3/12;;A42B3/122,A42B3/12;;A42B3/04,,0,0,,,,INACTIVE
59,US,A1,US 2017/0303621 A1,122-818-758-746-59X,2017-10-26,2017,US 201715647898 A,2017-07-12,US 201715647898 A;;US 201414549237 A,2014-11-20,SYSTEM AND METHOD FOR AIRBAG DEPLOYMENT AND INFLATION,"A helmet with an airbag assembly coupled to the shell of the helmet. The airbag assembly includes an airbag and an inflation device. The inflation device is configured to at least partially inflate the airbag upon deployment of the airbag assembly. The helmet also includes a s processing circuit disposed at least partially within the shell. The processing circuit is configured to receive helmet data regarding a second helmet, transmit deployment data regarding inflation of the airbag assembly, and control operation of the inflation device to inflate the airbag based on the helmet data.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2010-10-13),https://lens.org/122-818-758-746-59X,Patent Application,yes,5,1,3,3,0,A42B3/0486;;A42B3/0486;;A42B3/00;;A42B3/0406;;A42B3/046;;A42B3/122;;G08C17/02,A42B3/04;;A42B3/00;;G08C17/02,,0,0,,,,DISCONTINUED
60,US,B2,US 9788588 B2,075-446-153-707-46X,2017-10-17,2017,US 201514663315 A,2015-03-19,US 201514663315 A,2015-03-19,Helmet airbag system,An airbag inflation system includes a processing circuit configured to receive object data including positional data regarding an object and at least one of a relative velocity and a relative acceleration of the object relative to a first helmet and control operation of an inflation device to inflate an airbag based on the object data.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-06-02),https://lens.org/075-446-153-707-46X,Granted Patent,yes,24,14,3,3,0,A42B3/0486;;A42B3/0486;;A41D13/00;;A41D13/018;;A41D13/0512;;A42B3/00;;A42B3/12;;A42B3/122,A42B3/04,,2,0,,,"High tech football helmet with airbags, Retrieved from Youtube (http://www.youtube.com/watch?v=-XJrtk8MxvA), published Apr. 25, 2012, 2 pages.;;Welte, Rachel, “High tech football helmet with airbags”, Fox 21 News, Posted Apr. 25, 2012, 1 page.",INACTIVE
61,US,A1,US 2016/0331316 A1,179-983-584-809-972,2016-11-17,2016,US 201514713853 A,2015-05-15,US 201514713853 A,2015-05-15,IMPACT PREDICTION SYSTEMS AND METHODS,"An impact prediction system includes a processing circuit configured to receive remote tracking data from a remote tracking system located remote from a plurality of users, receive local tracking data from a plurality of local tracking devices, each local tracking device is worn by a different one of the plurality of users, and predict an impact between two or more of the plurality of users based on the remote tracking data and the local tracking data. The remote tracking data includes data regarding a location of each of the plurality of users. The local tracking data includes data regarding movement of each of the plurality of users.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHEATHAM III JESSE R;;DUNCAN WILLIAM D;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-02-02),https://lens.org/179-983-584-809-972,Patent Application,yes,4,6,1,1,0,A61B5/1113;;A61B5/1114;;A61B2503/10;;A61B5/6803;;A61B5/6803;;G01P15/02;;A63B24/0021;;A63B2024/0028;;A63B2024/0025;;A61B5/1113;;A61B5/1114;;A61B2503/10,A61B5/00;;G01P15/02,,0,0,,,,DISCONTINUED
62,US,B1,US 9384645 B1,098-982-090-027-873,2016-07-05,2016,US 201514600541 A,2015-01-20,US 201514600541 A,2015-01-20,System and method for impact prediction and proximity warning,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM D;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-02-06),https://lens.org/098-982-090-027-873,Granted Patent,yes,21,13,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/00;;G08B3/10;;G08B6/00;;G08B21/04,,1,0,,,"PCT International Search Report; International App. No. PCT/US2016/013899; Apr. 29, 2016; pp. 1-3.",INACTIVE
63,US,A1,US 2018/0200603 A1,020-379-064-275-666,2018-07-19,2018,US 201815922381 A,2018-03-15,US 201815922381 A;;US 201514694722 A,2015-04-23,SYSTEMS AND METHODS FOR DETERMINING PENALTIES,"A penalty allocation system includes a first equipment, a second equipment, and a processing circuit. The first equipment is configured to be worn by a first player. The first equipment includes a signal-carrying material configured to carry a signal. The second equipment is configured to be worn by a second player. The second equipment includes a sensor configured to acquire signal data from the signal in response to the sensor of the second equipment directly engaging the signal-carrying material during an impact between the first equipment and the second equipment. The processing circuit is configured to determine at least one of a penalty and a reward for a recipient regarding the impact between the first player and the second player based on the signal data. The recipient includes at least one of the first player and the second player.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;CHIN HON WAH;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WHITMER CHARLES;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/020-379-064-275-666,Patent Application,yes,28,3,3,3,0,A63B71/0605;;A63B71/0605;;A63B71/08;;A63B2024/0037;;A63B2024/0037;;A63B2071/068;;A63B2071/068;;A63B2102/14;;A63B2102/24;;A63B2220/12;;A63B2220/12;;A63B2220/13;;A63B2220/13;;A63B2220/14;;A63B2220/14;;A63B2220/20;;A63B2220/20;;A63B2220/30;;A63B2220/30;;A63B2220/40;;A63B2220/40;;A63B2220/53;;A63B2220/53;;A63B2220/56;;A63B2220/56;;A63B2220/801;;A63B2220/801;;A63B2220/803;;A63B2220/803;;A63B2225/20;;A63B2225/20;;A63B2225/50;;A63B2225/50;;A63B2225/54;;A63B2225/54;;A63B2243/0025;;A63B2243/0025;;A63B2243/0066;;A63B2243/0066;;G01S13/72;;G01S13/72;;G01S17/66;;G01S17/66;;G01S19/19;;G01S19/19;;G01S19/51;;G01S19/51,A63B71/06,,0,0,,,,DISCONTINUED
64,US,A1,US 2016/0267763 A1,137-014-546-285-614,2016-09-15,2016,US 201615158979 A,2016-05-19,US 201615158979 A;;US 201514688775 A;;US 201514600541 A,2015-01-20,SYSTEM AND METHOD FOR IMPACT PREDICTION AND PROXIMITY WARNING,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID LOZOFF;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM DAVID;;ELLENBOGEN RICHARD GLEN;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY VINSON;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/137-014-546-285-614,Patent Application,yes,9,10,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/04;;G08B3/10;;G08B5/36;;G08B6/00;;G08G1/16,,0,0,,,,INACTIVE
65,US,A1,US 2016/0210837 A1,152-498-231-785-152,2016-07-21,2016,US 201514688775 A,2015-04-16,US 201514688775 A;;US 201514600541 A,2015-01-20,SYSTEM AND METHOD FOR IMPACT PREDICTION AND PROXIMITY WARNING,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP B;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM D;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/152-498-231-785-152,Patent Application,yes,0,4,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/04,,0,0,,,,INACTIVE
66,US,B2,US 10181247 B2,124-283-022-235-601,2019-01-15,2019,US 201615158979 A,2016-05-19,US 201615158979 A;;US 201514688775 A;;US 201514600541 A,2015-01-20,System and method for impact prediction and proximity warning,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID LOZOFF;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM DAVID;;ELLENBOGEN RICHARD GLEN;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY VINSON;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/124-283-022-235-601,Granted Patent,yes,27,0,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/04;;G08B3/10;;G08B5/36;;G08B6/00;;G08G1/16,,0,0,,,,INACTIVE
67,US,A1,US 2019/0108741 A1,104-283-299-767-461,2019-04-11,2019,US 201816210179 A,2018-12-05,US 201816210179 A;;US 201615158979 A;;US 201514688775 A;;US 201514600541 A,2015-01-20,SYSTEM AND METHOD FOR IMPACT PREDICTION AND PROXIMITY WARNING,"A sensing and warning system includes a sensor configured to generate data regarding at least one of a user or an object, a warning device configured to be positioned on the user, and a processing circuit. The processing circuit is configured to receive the data from the sensor, determine a command based on the data, and transmit the command to the warning device prior to an impact between the user and the object. The warning device is configured to implement the command to provide a warning to the user in an attempt to (i) prevent the impact or (ii) reduce a magnitude of the impact between the user and the object.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM D;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/104-283-299-767-461,Patent Application,yes,3,2,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/04;;G08B3/10;;G08B5/36;;G08B6/00;;G08G1/16,,0,0,,,,DISCONTINUED
68,WO,A1,WO 2016/118501 A1,036-907-621-151-47X,2016-07-28,2016,US 2016/0013899 W,2016-01-19,US 201514600541 A,2015-01-20,SYSTEM AND METHOD FOR IMPACT PREDICTION AND PROXIMITY WARNING,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM JESSE R III;;DUNCAN WILLIAM DAVID;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD LOWELL L JR;;WOOD VICTORIA Y H,,https://lens.org/036-907-621-151-47X,Patent Application,yes,5,1,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G01P13/00;;G06F17/50,,0,0,,,,PENDING
69,CN,A,CN 107430801 A,189-439-558-555-247,2017-12-01,2017,CN 201680013634 A,2016-01-19,US 201514600541 A;;US 2016/0013899 W,2015-01-20,SYSTEM AND METHOD FOR IMPACT PREDICTION AND PROXIMITY WARNING,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM JESSE R III;;DUNCAN WILLIAM DAVID;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD LOWELL L JR;;WOOD VICTORIA Y H,,https://lens.org/189-439-558-555-247,Patent Application,no,4,1,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/04,,0,0,,,,DISCONTINUED
70,US,B2,US 10086251 B2,001-781-193-431-035,2018-10-02,2018,US 201514694722 A,2015-04-23,US 201514694722 A,2015-04-23,Systems and methods for determining penalties,"A penalty allocation system includes a processing circuit configured to receive first data from a first player-worn sensor regarding a first player involved in an impact, receive second data from a second player-worn sensor regarding a second player involved in the impact, identify one of the first player and the second player as an at-fault player in connection with the impact based on the first data and the second data, and determine a penalty for the at-fault player based on the first data and the second data.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;CHIN HON WAH;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WHITMER CHARLES;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-08-06),https://lens.org/001-781-193-431-035,Granted Patent,yes,19,0,3,3,0,A63B71/0605;;A63B71/0605;;A63B71/08;;A63B2024/0037;;A63B2024/0037;;A63B2071/068;;A63B2071/068;;A63B2102/14;;A63B2102/24;;A63B2220/12;;A63B2220/12;;A63B2220/13;;A63B2220/13;;A63B2220/14;;A63B2220/14;;A63B2220/20;;A63B2220/20;;A63B2220/30;;A63B2220/30;;A63B2220/40;;A63B2220/40;;A63B2220/53;;A63B2220/53;;A63B2220/56;;A63B2220/56;;A63B2220/801;;A63B2220/801;;A63B2220/803;;A63B2220/803;;A63B2225/20;;A63B2225/20;;A63B2225/50;;A63B2225/50;;A63B2225/54;;A63B2225/54;;A63B2243/0025;;A63B2243/0025;;A63B2243/0066;;A63B2243/0066;;G01S13/72;;G01S13/72;;G01S17/66;;G01S17/66;;G01S19/19;;G01S19/19;;G01S19/51;;G01S19/51,A63F9/24;;A63B24/00;;A63B71/06;;A63B71/08;;A63B102/14;;A63B102/24;;A63F13/00;;G01S13/72;;G01S17/66;;G01S19/19;;G01S19/51;;G06F17/00;;G06F19/00,,0,0,,,,INACTIVE
71,US,A1,US 2016/0210836 A1,120-844-083-187-107,2016-07-21,2016,US 201514600541 A,2015-01-20,US 201514600541 A,2015-01-20,SYSTEM AND METHOD FOR IMPACT PREDICTION AND PROXIMITY WARNING,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM D;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-02-06),https://lens.org/120-844-083-187-107,Patent Application,yes,0,6,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,G08B21/04;;G08B3/10;;G08B6/00,,0,0,,,,INACTIVE
72,US,B1,US 9396641 B1,094-554-768-767-466,2016-07-19,2016,US 201514688775 A,2015-04-16,US 201514688775 A;;US 201514600541 A,2015-01-20,System and method for impact prediction and proximity warning,A system for predicting and warning of impacts includes a sensor located remote from a user and configured to acquire user data regarding motion of the user and object data regarding motion of the object; and a processing circuit configured to predict a potential impact between the user and the object based on the user data and the object data; and control operation of a user-wearable warning device to provide a warning output to the user in advance of a predicted time of the potential impact.,ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;DUNCAN WILLIAM D;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,,https://lens.org/094-554-768-767-466,Granted Patent,yes,21,1,9,9,0,G08B21/0446;;G08B21/0446;;G08B21/0446;;G08B3/10;;G08B5/36;;G08B6/00;;G08B21/0438;;G08B21/0461;;G08G1/166,A42B1/06;;A61B5/00;;G01P15/00;;G08B1/08;;G08B21/04;;G08B23/00,,1,0,,,"PCT International Search Report; International App. No. PCT/US2016/013899; Apr. 29, 2016; pp. 1-3.",INACTIVE
73,US,A1,US 2016/0310819 A1,167-338-698-327-94X,2016-10-27,2016,US 201514694722 A,2015-04-23,US 201514694722 A,2015-04-23,SYSTEMS AND METHODS FOR DETERMINING PENALTIES,"A penalty allocation system includes a processing circuit configured to receive first data from a first player-worn sensor regarding a first player involved in an impact, receive second data from a second player-worn sensor regarding a second player involved in the impact, identify one of the first player and the second player as an at-fault player in connection with the impact based on the first data and the second data, and determine a penalty for the at-fault player based on the first data and the second data.",ELWHA LLC,ALLEN PAUL G;;BAYLY PHILIP V;;BRODY DAVID L;;CHAN ALISTAIR K;;CHEATHAM III JESSE R;;CHIN HON WAH;;ELLENBOGEN RICHARD G;;HYDE RODERICK A;;ISHIKAWA MURIEL Y;;KARE JORDIN T;;LEUTHARDT ERIC C;;MYHRVOLD NATHAN P;;PAN TONY S;;PETROSKI ROBERT C;;RADOVITZKY RAUL;;SMITH ANTHONY V;;SWEENEY ELIZABETH A;;TEGREENE CLARENCE T;;TOURAN NICHOLAS W;;WHITMER CHARLES;;WOOD JR LOWELL L;;WOOD VICTORIA Y H,ELWHA LLC (2015-08-06),https://lens.org/167-338-698-327-94X,Patent Application,yes,8,6,3,3,0,A63B71/0605;;A63B71/0605;;A63B71/08;;A63B2024/0037;;A63B2024/0037;;A63B2071/068;;A63B2071/068;;A63B2102/14;;A63B2102/24;;A63B2220/12;;A63B2220/12;;A63B2220/13;;A63B2220/13;;A63B2220/14;;A63B2220/14;;A63B2220/20;;A63B2220/20;;A63B2220/30;;A63B2220/30;;A63B2220/40;;A63B2220/40;;A63B2220/53;;A63B2220/53;;A63B2220/56;;A63B2220/56;;A63B2220/801;;A63B2220/801;;A63B2220/803;;A63B2220/803;;A63B2225/20;;A63B2225/20;;A63B2225/50;;A63B2225/50;;A63B2225/54;;A63B2225/54;;A63B2243/0025;;A63B2243/0025;;A63B2243/0066;;A63B2243/0066;;G01S13/72;;G01S13/72;;G01S17/66;;G01S17/66;;G01S19/19;;G01S19/19;;G01S19/51;;G01S19/51,A63B71/06,,0,0,,,,INACTIVE
